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ABSTRACT
Information relating to the extent of the use of substances in Irish Industry which are 
classified as ‘skin sensitisers’ is difficult to obtain, as details regarding the volume of 
these substances imported into Ireland on an annual basis is not available. Occupational 
skin diseases are the most frequently encountered occupational disease. Despite the fact 
that occupational skin disease often parallels the level of hygiene practiced by employers, 
occupational skin disease is largely preventable.
For technical reasons there are still no skin exposure limits to guide employers, nor 
techniques to measure skin exposure levels. Currently the use of substances which have 
the potential to cause skin sensitisation are widely used in Irish industry. There is a 
requirement to develop a structured approach to the management of operations where 
there is the likelihood of worker exposure to an agent, which has the potential to cause 
skin disease. Risk assessments are necessary procedures for the evaluation of working 
conditions and the potential for damage to the health of the employees from their specific 
tasks. When proper skin management procedures are in place the hazards of a substance 
can be identified and adequate control measures be implemented before a substance 
enters the work area.
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SECTION 1 
INTRODUCTION
S E C T I O N  1. I N T R O D U C T I O N
1.0 Background
This dissertation is concerned with the use and control of substances in Irish Industry, 
which are classified as ‘Skin Sensitisers’. Skin diseases that are caused by a substance 
or condition in the workplace are the most frequently encountered occupational illness. 
While there are systems in place for the control of exposure of workers to respiratory 
hazards and exposure limits available to employers, such information is not available 
with regard to non-respiratory hazards such as those associated with skin disease. There 
is very little data available on the reported cases o f occupational dermatitis and most of 
the data gathered is to assess the economic implications rather than the Health and 
Safety implications.
1.1 Aims and Objectives
(i) To provide a review of the literature and research works of others so as to
ascertain, the incidence and prevalence of skin diseases and to distinguish 
between skin diseases which are as a result o f exposure to irritants and those 
which are sue to exposure to substances which cause allergic reactions in the 
skin.
(ii) To review legislation and examine what information is available on skin
sensitising substances.
(iii) To survey Irish Industry to gather information on the extent o f the use of
substances, which have the potential to cause, skin sensitisation. To evaluate
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the incidence of occupational skin disease within Irish Industry and assess how 
exposure control is managed.
(iv) To study the available statistical data available on the incidence of occupational 
skin disease and to establish whom is involved in the data gathering and the 
surveillance of occupational skin disease.
1.2 Methodology
So as to facilitate the literature review, library searches were carried out from the 
British Library, University College Galway and University College Dublin. Information 
was gathered from the World Health Organisation, Health and Safety Commission in 
Britain, Health and Safety Authority of Ireland, the Department of Health and the 
Department of Social Welfare. Various publications were purchased from the 
Government Publications Office and the National Institute of Occupational Safety and 
Health.
The legislation reviewed included current and proposed national and European 
legislation.
Information on the use and control of substances which are classified as ‘Skin 
Sensitisers’ was gathered from survey questionnaires sent to industries and from 
information collected from the Department of Health and the Health and Safety 
Authority o f Ireland.
SECTION 2 
LITERATURE REVIEW
S E C T I O N  2.  L I T E R A T U R E  R E V I E W
SUB-SECTION 2.1 THE SKIN AS A BARRIER 
2.1(a) The structure and composition of the human skin.
In order to understand how skin disorders occur and to distinguish between those which 
are occupational and those which have little or nothing to do with the workplace it is 
necessary to have an understanding of the way in which the skin works. The correct 
functioning of the skin is vital if we are to survive. The skin barrier layer is very thin and 
easily damaged. To examine the way in which the skin works to protects us we need to 
know how it functions and how it is constructed.
The Skin
Fig.l The structure of the human skin. (Adaptedfrom ‘Science Today’ Kennedy, Porter, Scott, 1985)
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The skin is the largest organ of the body forming an average around 10% of our total 
body weight and with a surface area of 2,880 square inches or 19 square feet. The skin 
is the body’s outer layer and therefore as such it forms a two-way barrier. It not only 
works to prevent substances from the outside world from gaining access to internal 
organs but also retains body fluids. The skin is a tough flexible cover and because it is 
the first body barrier to come into contact with the elements, as well as industrial 
hazards o f every type, the skin is subjected to attack from heat, cold, moisture, 
radiation, all kinds of dirt, fungus, bacteria, and penetrating objects (Anon, 1975a).
There are three distinct layers of tissue that make up the skin, the epidermis the dermis 
and the subcutaneous layer. The thickness of the skin varies from 0.5mm on the eyelid 
(the dermis is the thinnest here) to 3 or 4mm on the palms of the hand and soles of the 
feet (the epidermis is thickest here). The palms of the hands and the soles of the feet can 
have as many as sixty layers of cells whereas in some areas notably in the skin folds the 
axillae (armpits), the groin, under the breast and between the fingers and toes (Olishifski, 
1988).
From the outside of the skin structure we find the lipid (oily) layer on the surface. This 
lipid layer has an acid pH, and it is composed of oil and sweat and can be easily washed 
off even with plain water. Beneath this lipid layer is epidermal cells variously called the 
homy layer, stratum comeum, or keratin layer. This layer stands up fairly well against 
chemical attack with the notable exception of alkalis. The layer is the chief barrier 
against water and aqueous solutions, but it offers no protection against lipid-soluble
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materials such as solvents or gases. As the cells migrate and slowly transform from 
keratinocyte into comeocyte, small sacks appear within the cell filled with lameller 
bodies. The horny layer or stratum corneum, made up of several comeocytes, is 
constantly being replaced by cells pushed toward the surface as new cells are formed in 
the deeper germinative layer of the epidermis. This sloughing and regenerative 
characteristic serves to some extent to protect against chemicals and microorganisms.
There are four types of cells in the epidermis;
• Kératinocytes which make up the bulk of the epidermis form from below and move 
up to become dead homy cells.
• Melanocytes are cells which synthesise melanin (pigment) granules which are then 
transferred to kératinocytes. It is the amount of melanin in kératinocytes that 
determines the degree of pigmentation of skin and hair. Melanin proliferates under 
stimulus of certain wavelengths of sunlight and becomes visible as suntan or freckles. 
Albinism is an inherited abnormality in which melanin production is decreased. 
Vitiligo is a more common disorder where a loss in melanocytes results in areas of 
cutaneous pigment loss.
Occupational or environmental exposure to certain chemicals e.g. phenolic germicides 
can destroy pigment (Olishifski, 1988). Fukuyama et al. (1982) and Yonemoto et al. 
(1983), carried out studies on the pathomechanisms of chemically induced 
depigmentation by using tertiary butyl catechol (TBC) as the prototype depigmenting
compound Anatomic alterations in melanin biosynthesis and in melanosomes have been 
clarified. In vivo and in vitro methods were employed on mouse and guinea pig skin and 
human melanoma cell lines. Assay of enzymes involved in melanin formation and light 
and electron microscopy have been employed. The major findings have included 
“conversion from eumelanin to pheomelanosome synthesis, enzymatic changes (in the 
melanocyte) such as increased activity of glutathione reductase and gamma-glutamyl 
transpeptidase, increased sulfus content of TBC-treated cells, and lightening of the 
melanocytes. Mice and guinea pig models were recommended for predictive screening 
for depigmentation produced by topically applied chemicals.
• Langerhan’s cells, which are located in the mid-epidermis, play an important role in 
various immune process, especially allergic contact dermatitis and they account for 
four percent of all epidermal cells.
• Merkel cells function as slowly adapting receptors of the touch sensation.
The Lamellar bodies form the “seal” which keeps most of the moisture in the body 
permitting only enough to permeate through to keep the outer layers adequately moist. 
If this moisture were allowed to evaporate the stratum comeum would become more 
permeable. The layer is only a few microns thick and is essential for the correct 
functioning of our body. Any substance which has the capability of either emulsifying 
or dissolving fatty substances, is a potential hazard to the skin. Studies carried out by 
Overgaard ei al. 1993, showed that if the barrier of the skin is measured by the amount
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of moisture lost (trans-epidermal water loss - TEWL) then it can be shown that even 
plain water will affect the ability of the skin to provide protection as the TEWL will have 
increased.
The epidermis is not richly supplied with blood but it is bathed in lymph, a fluid derived 
from the blood. The epidermis is thin enough so that the nerve endings in the dermis are 
close and therefore supply the fine sense of touch. Beneath the epidermis is the dermis 
characterised by collagenous (connective) tissues which are a matrix o f fibres called 
collagen and elastin in a base of jelly like substance. It is these fibres that give the 
dermis it tensile strength and toughness.
The dermis is the main natural protection against trauma and when injured, it can form 
new tissues in the form of a scar to repair itself. The dermis is laced with blood vessels, 
nerve fibres, receptor organs for sensations of touch, pain, heat and cold, contains 
muscular elements, hair follicles, and oil and sweat glands. A layer of tiny cone-shaped 
objects called papillae are present at the top of the dermis. Nerve fibres and special 
nerve endings are found in many of the papillae. The dermis is supplied with nerves to 
warn of changes in the environment, in addition to hair follicles, oil and sweat glands, 
and blood and lymph vessels. The sweat produced by the sweat glands may act as a 
protective mechanism to wash away an irritant but may also result in a chemical going 
into solution which may allow it to penetrate the skin more readily.
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Both the hair follicles and the sweat glands serve as routes of entry into the body 
through the skin. Physicians sometimes exploit the absorptive capability of the skin to 
administer certain drugs. Some chemicals that are placed on the skin can be detected in 
saliva a few minutes later. The absorptive characteristics of the skin can be an 
unfortunate one from the point of view of occupational health. Beneath the dermis is a 
layer of subcutaneous tissue with fatty and resilient elements which help cushion and 
insulate the skin above it. Present in the subcutaneous layer which distinguishes it from 
the other parts of the skin is fat. In the lower parts of this layer also lie eccrine and 
apocrine sweat glands and hairs as well as nerves, blood and lymphatic vessels, cells, and 
fibrous partitions composed of collagen, elastic tissue and reticulum. It links the dermis 
with tissue covering the muscles and bones (Anon, 1975a).
2.1(b) The Functions of the Human Skin
The skin performs a number of important functions and among these are the protection 
o f the body against invasion of bacteria, against injury to vital internal organs, against 
the rays of the sun and against the loss of moisture.
The skin protects in the following ways:
1. The skin protects against physical damage and trauma, by the skin armed with 
sensory signals, by the strong resilient collagen tissue, and by its self repairing 
properties.
2. The skin has the defense of being naturally dry terrain (except in places like armpits, 
and in the groin, and during abnormal sweating), and has a normal contingent of 
bacteria that tends to destroy pathogenic bacteria. Free fatty acid oils in the surface 
oil may also have some antibacterial value.
3. Against sunlight, the skin has two defence mechanisms which include an increase in 
pigmentation and a responsive swelling to increase thickness.
4 The skin may protect against primary irritants by the natural defences such as the 
buffered acid mantle, the stratum comeum, thickening of the Keratin material and 
sweating.
5. Against the absorption of water and water soluble chemicals, there is considerable 
protection. Strong acids and caustics will produce chemical bums in short order.
6. The skin can offer like no protection in use, absorption of lipid-soluble chemical. 
Certain fat soluble chemicals such as benzene, carbon tetrachlorine, and carbon 
disulphide go through the skin easily and may cause serious system damage, or even 
fatal effects. The majority of solvents such as trichlorethylene naphtha, and toluene 
do not readily penetrate the lipid layer, but only prolonged contact with large skin 
areas will result in appreciable skin penetration (Anon, 1975a).
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SUB-SECTION 2.2 MECHANISMS OF SKIN ABSORPTION
2.2(a) Dermal Absorption
The skin is made up of various types of cells which as mentioned in earlier sections form 
three distinct layers; the epidermis, the dermis and the hypodermis (consisting mainly of 
connective tissue and fat). Percutaneous absorption involves diffusion of the chemical 
through these layers until it reaches capillaries in the epidermis and hypodermis, and 
enters the systemic circulation. The epidermis also has a limited enzyme system and 
these can metabolise xenobiotics (Kao et al. 1985). Dermal absorption involves two 
major diffusion processes penetration through the stratum comeum and transfer into the 
capillary blood.
2.2(b) Dermal Penetration
Penetration through the stratum comeum, by diffusion via polar and lipophilic pathways, 
is restricted to small molecules (molecular weigh < 500). High solubility in water and in 
fat facilitates rapid penetration. The measure of penetration is either the permeability 
coefficient (which is the velocity constant in cm h -1) or flux (which is the penetration 
rate in mgcm-2 h-1). Flux (Fl)and permeability coefficient (K) are related by the 
equation.
Equation 1 FI = k A C.
where AC is the concentration gradient across the stratum comeum.
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Both K an d FI vary over the body, depending on the composition and thickness of the 
stratum comeum, the presence of skin appendages (hair glands) and the amount of 
perspiration. The differences among animal species are even larger (Wester et al. 1977). 
Environmental temperature and humidity and, most importantly, the dispersant 
(vechicle) in which the chemical is administered also affect penetration (Dutkiewicz et 
al. 1961). Moreover, the nature of the skin and thus flux can be gradually altered by the 
applied chemical or by the dispersant. K and FI can be measured both in vivo and in 
vitro.
The determination of the concentration on the receptor side of the skin is the most 
controversial step in the measurement. The methods were recently reviewed by the 
Environmental Protection Agency (1992). Because of differences in skin composition 
and in methodology the results reported vary widely. For example, the flux of Xylene, 
measured in a diffusion chamber using excised rat skin, was 0.006 mgcm-2h-l (Tsuruta, 
1982), whereas excretion of metabolites in humans indicates a flux of 0.13 mgcm-2h-l 
(Engstrom et al. 1977).
Several theoretical approaches for the prediction of dermal penetration rate based on the 
physiological function of the skin and on the chemical structure and physical properties 
o f the chemical were developed. Models based on similarity of chemical structure are 
reviewed in the EPA Interim report on dermal exposure assessment (EPA, 1992). Other 
models are based on the diffusion process and on the physiochemical properties of the
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chemical and skin composition. In these models penetration is defined either by 
permeability coefficients (EPA, 1992) or by flux (models reviewed by Osbourne, 1986).
Although the permeability constant is time - independent, the penetration rate changes 
during the exposure as does the concentration gradient across the skin (Equation I). In 
vivo, the change is apparent at the beginning of the exposure but becomes negligible 
when the apparent steady state is approached.
2.2(c) The Distribution and Elimination of Percutaneously Absorbed Chemicals
The transfer of the chemical from the dermis, into the capillary blood depends on the 
perfusion rate of the dermis, (and thus on physical activity of the person and 
environmental temperature), and on the dermis blood distribution coefficient of the 
chemical, (and thus on body fat and on the hydration of the skin), (Fiserova- Bergerova, 
1990).
At the beginning of exposure, when the absorption rate is a function of time, the 
concentration builds up in the epidermis and dermis. During this period, the 
concentration gradient diminishes. The absorption rate becomes constant after the lag 
time period, when steady state is approached (that is, when the penetration and uptake 
rates are equal and the concentration gradients are constant). The rate limiting step is 
usually the penetration rate through the stratum comeum, but for lipophilic chemicals in 
poorly perfused areas it may be the removal of the chemical from the skin by capillary 
blood. Pharmaco-kinetic models were developed to describe the distribution and
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elimination of percutaneously absorbed chemicals (Fiserova-Bergerova et al. 1990, Guy 
el al. 1985). The passing of the chemical into the capillary blood at steady state can be 
described by a balance equation.
Equation 2 Inflow = Outflow.
FCart + FI = FCven
where F is the perfusion rate of skin under the exposed area and Cart and are 
concentrations of the chemical in arterial blood and venous blood under the exposed 
area, respectively. If the diffusion is rapid, as in the case of volatile solvents, the 
concentrations in blood, alveolar air and dermis are instantly equilibrated and equation 2 
can be rewritten in order to compare penetration rate with uptake rate;
Equation 3 FI F (Cderm ^ bl/derm~ f'alv A. bl/air)
where Cdenn and Caiv are concentrations of the chemical in skin under the exposed area 
and in alveolar air, respectively, and V s  are the appropriate partition coefficient 
(Fiserova-Bergerova, 1990).
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SUB-SECTION 2.3 CONTACT DERMATITIS
2.3(a) Contact Dermatitis
A number of different morphologic types of cutaneous reactions may occur when skin is 
topically exposed to chemical agents. The initial interation can lead to a variety of cell 
and agent-dependent biologic events resulting in an array of cutaneous and even 
systemic responses. These may include localised or generalised urticaria with and 
without anaphylaxis, which is mediated by most cell activation; acneiform eruptions in 
melanocyte biology resulting in hypopigmentation or hyperpigmentation; interaction of 
the chemical agent with non-ionising radiation and effects on dermal vessels that result 
in atropy or purpura. The most common pathologic response pattern resulting from skin 
contact with a chemical agent is contact dermatitis. Even the most experienced 
dermatologist can have difficulty distinguishing the two, as the signs, symptoms, and 
even histopathology overlap (Marks et al. 1997a).
2.3(b) Irritant Contact Dermatitis
An irritant is any substance that damages and causes an inflamatory reaction in the skin 
by direct action through a nonimmune mechanism. Several factors help determine the 
security of the skin reaction. They include properties of the irritant, such as pH, 
solubility, physical state (gas, liquid, or solid), and host factors. Host factors include the 
area of affected skin, oil gland and sweat gland activity, and the presence of or tendancy 
toward other skin diseases. Environmental factors such as temperature and humidity 
also play a role. Irritant dermatitis can occur in anyone if the concentration of an irritant
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is high enough and the exposure is long enough. The hands and forearms are affected 
most often. Clinical findings in irritant dermatitis vary from mild erythema, itching and 
chapping to severe blistering and ulceration. The worst cases can be categorised as 
chemical bums, but most cases are mild. Mild cases may be insidious in onset. The 
dermatologist should be alert to the fact that chronic irritant dermatitis may be 
indistinguishable from allergid contact dermatitis. Even when a patient clearly has an 
irritant dematitis, definitive diagnosis frequently can pick up an additional allergic 
etiology (Skellchock., 1995).
2.3(c) Allergic Contact Dermatitis
Allergic contact dermatitis can be defined as an acquired delayed, cell mediated reaction. 
The body’s immune system recognises a foreign substance and responds in defence 
through a very complex interaction between many different cells, molecules and 
enzymes. Sensitising agents differ from primary irritants in their mechanism of action 
and their effect on the skin. Unless they are concomitant irritants, most sensitisers do 
not produce a skin reaction on first contact.
An essential difference between primary irritation and allergic contact dermatitis is that 
an irritant usually affects a number of people whereas a sensitiser generally only affects a 
few. Exceptions exist as in the case of potent sensitisers such as poison oak or epoxy 
resin and components. Differentiation of marginal irritants and cutaneous sensitisers 
may be extremely difficult. The former may require repeated or prolonged exposure 
before a dermatitis appears. Development of allergic contact dermatitis may not occur
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for months or years after exposure to an agent, and sensitisation may be produced or 
maintained by allergens in minute amounts and in concentrations insufficient to irritate 
the nonallergic skin e.g. Nickel, chromates, formaldehyde and turpentime. Cross­
sensitivity is an important phenomenon in which a person sensitised to one chemical will 
also react to one or more closely related chemicals. Patch testing is an important 
diagnostic tool in differentiating allergic contact dermatitis from irritant dermatitis 
(Taylor, 1982).
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SUB-SECTION 2.4 ALLERGY AND THE IMMUNE SYSTEM
2.4(a) The human body and the immune system
The human body possesses what we call the immune system, which is a highly complex 
network of molecules and cells. This system is designed to protect us from bacteria, 
viruses, chemicals and parasites. It does this by distinguishing between ‘self and ‘non­
self. The system is continuously checking to identify ‘foreign bodies’. If a body is 
recognised as ‘foreign’, then one of a series of defence mechanisms will come into play 
to deal with the invader either by destroying it or by rendering it harmless. These 
defence mechanisms are working for us virtually all the time, mostly without our being 
aware of this. Occasionally, they malfunction. They may react excessively either to 
something against which they should react or, commonly, to something which, whilst it 
may penetrate into our body, would normally be considered harmless. It is this 
overreaction which we generally call an Allergy or more accurately, hypersensitivity .
2.4(b) Allergic Reactions
Allergic reactions are those which occur when the immune system of the body is 
stimulated to react in a particular way. This may be the result o f a toxic molecule being 
sufficiently large to be regarded as foreign by the immune system so as to act as an 
antigen. Chemical allergy is an adverse reaction that results from previous sensitisation 
to a particular chemical or to one that is structurally similar. Such reactions are 
mediated by the immune systems. The term ‘hypersensitivity’ is often used to describe 
the allergic state. For a low-molecule weight chemical to cause an allergic reaction its
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or its metabolic product usually acts as a Hapten combined with an endogenous protein 
to form an antigenic complex. Such antigens induce the synthesis of antibodies, usually 
after a latent period of at least one or two weeks. Subsequent exposure of the organism 
to the chemical results in an antigen-antibody interaction that provokes the typical 
manifestation of allergy. Dose-response relationships are usually not apparent for the 
provocation of allergic reactions.
2.4(c) Types of Allergic Responses
The allergic responses have been divided into four general categories, based on the 
mechanism of immunological involvement.
^ T y p e  1 or anaphalactic reactions in man are mediated by IgE antibodies. The Fc 
portion of IgE can bind to receptors on Host cells and basaphils. If the antibody 
molecule then binds with antigen, various mediators (histamine, leuotrotrienes, 
prostaglandins) are released and they cause vasodilation edema and an inflamatory 
response. The main targets of this type of reaction are GIT (food allergies), the skin 
(utricary and atropic dermitis), the respiratory system (rhinitis and asthma) and the 
vasculature ( anaphylactic shock). These responses tend to occur quickly after 
challenge with an antigen to which the individual has been sensitized and are termed 
Immediate hypensitivity reactions.
^  Type 2 or cytalytic reactions mediated by both IgG and IgM antibodies and are 
usually attributed to their ability to activate complement. The major target tissues are
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the cells in the circulatory system and they can be destroyed. Examples of this 
phenomenon include penicillin - induced haemalytic anemia quinidine - induced 
granulocytopenia and hydralazine or procainamide - induced systemic lupus 
erythematosus. Fortunately, these autoimmune reactions to drugs usually subside 
within several months after removal of the offending agent.
=> Type 3 or Arthus reactions are predominantly mediated by IgG; the mechanism 
involves the generation of antigen - antibody complexes that subsequently fix 
complement. The complexes become deposited in the vascular endothelium where a 
destructive inflammatory response called serum sickness occurs. This is in contrast 
to the Type 2 reaction in which the inflamatory response is induced by antibodies 
directed against tissue antigens. The clinical symptoms of serum sickness include 
urticarial skin erruptions, arthralagia, or arthritis lymphadenopathy, and fever. These 
reactions usually last for six to twelve days and then subside after the offending agent 
is eliminated. Several drugs, such as sulfonamides penicillins, certain anticonvulsants, 
and iodides, can enduce serum sickness. Stevens Johnson syndrome such as that 
caused by sulfonamides, is a more severe form of immune vasculitis. Symptoms of 
this reaction include erythema multiforme arthritis nephritis, CNS abnormalities and 
mycocarditis.
=> Type 4 or delayed-hypersensitivity reactions are mediated by sensitized lymphocytes 
and macrophages. When sensitized cells come in contact with antigen, an
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inflammatory reaction is generated by the production of lymphotines and the 
subsequent influx of neutrophil and macrophages (Packham, 1998c)
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SUB-SECTION 2.5 SKIN SENSITISATION REACTIONS
2.5(a) Type IV Reactions
Allergic contact dermatitis is a classic delayed hypersensitivity, or a Type 4 immunologic 
reaction. By definition it is mediated by immune cells rather than by antibodies. The 
reaction can be thought of as occurring in two phases, initially a sensitisation and then an 
elicitation response. It is the first or sensitisation phase that is the basis for its 
classification as an immune-mediated reaction
2.5(b) Sensitisation Phase
The allergen is a chemical that is usually, but not always, o f low molecular weight, lipid 
soluble, and highly reactive. An unprocessed allergen is more correctly referred to as a 
hapten. The hapten is applied to the stratum cormeum, penetrates to the lower layers of 
the epidermis, and is taken up by the Langerhans’ cell by pinocytosis. Within the cell 
lysosomal or cytosolic enzymes chemically alter the hapten, and it is conjugated to a 
newly synthesized HLA-DR molecule to form the complete antigen. This complex is 
expressed on the surface of the Langerhans’ cell.
The next step is presentation of the HLA-DR-antigen complex to specific helper T cells 
that express both a CD4 molecule that recognizes the HLA-DR o f the Langerhans’ cells 
and more specifically a T-cell receptor-CD3 complex that recognizes the processed 
antigen. The presence or absence of specific T cells is most likely genetically 
determined. As stated earlier, this specificity that allows interaction with thousands of
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antigens is developed by T-cell receptor rearrangements during early thymus 
development. It is unlikely that this initial HLA-DR-antigen and T-cell receptor-CD3 
interaction occurs in the skin. It is believed that the Langerhans’ cell migrates via the 
lymphatics to regional nodes where it presents the HLA-DR- antigen complex to 
specific T cells. Once antigen recognition occurs, both cells are activated. A series of 
cytokines is synthesized by both the Langerhans’ cell and the T cell. Within the T cell 
this message is transmitted via the CD3 molecule.
The Langerhans’ cell secretes EL-1, which stimulates the T cell to secrete IL-2 and to 
express IL-2 receptors. This cytokine leads to stimulation of T-cell proliferation, 
thereby expanding the clone of specific T cells capable of responding to the inciting 
antigen. This occurs during the classic lag phase of sensitisation. The primed or 
memory T cells that are generated are now much expanded as compared with the 
original population of cells with the specific T-cell receptor, and they leave the node and 
circulate throughout the body. The individual is now sensitised, or primed, to respond 
when these circulating T cells are re-exposed to antigen.
2.5(c) Elicitation Phase
The second phase, or elicitation of the delayed type of hypersensitivity, occurs on 
reexposure. Once again, hapten diffuses to the Langerhans’ cell, it is taken in and 
chemically altered, it is bound to the HLA-DR, and the complex is expressed on the 
surface of the Langerhans’ cell. The complex interacts with primed T cells in either the
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skin or the node (or both), and the activation process takes place. In the skin the 
interaction is even more complex because other cells are present.
Langerhans’ cells secrete IL-1, which stimulates the T cell to produce IL-2 and express 
IL-2R. Once again, this leads to proliferation and expansion of the T-cell population, 
this time within the skin. In addition, the activated T cells secrete IFN-y, which 
activates the keratinocyte and causes it to express both ICAM-1 and HLA-DR. The 
ICAM-1 molecule allows the keratinocyte to interact with T cells and other leukocytes 
that express the LFA-1 molecule. Expression of HLA-DR allows for the keratinocyte to 
interact directly with CD4-bearing T cells and may allow for antigen presentation to 
these cells as well.
In addition, HLA-DR expression may make the keratinocyte the target for cytotoxic T 
cells. Activated kératinocytes also produce a number of cytokines, including IL-1, 11-6, 
and GMCSF, all of which can further expand the involvement and activation of T cells. 
In addition, IL-1 can stimulate kératinocytes to produce eicosanoids. This combination 
of cytokines and eicosanoids leads to activation of mast cells and macrophages. 
Histamine from mast cells and eicosanoids from mast cells, kératinocytes, and infiltrating 
leukocytes lead to vascular dilation and increased permeability to circulating pro- 
inflammatory soluble factors and cells. This cascade leads to the clinical ACD response 
of inflammation, cellular destruction, and reparative processes (Rietschel et al. 1995a).
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fType IV - Sensitization process
Type IV - Elicitation of allergic reaction
Fig. 3 Sensitisation and Elicitation Reactions. Taken from Packham, 1998
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In addition to sensitisation followed by the elicitation scenario outlined earlier, exposure 
to antigen may also result in activation of suppressor pathways. The net balance of 
sensitisation and suppression resulting in disease or no disease on exposure to antigen 
depends on many factors. Presentation of a high concentration of antigen during the 
first exposure may result in the generation of specific suppressor T cells. Exposure to 
antigen through a site other than skin (eg, orally or intravenously) may also result in 
specific suppressor-cell generation. Such responses may be due to exposure of T cells 
to antigen that has not been processed by Langerhans’ cells.
Many other poorly understood processes surely “downregulate” the immune response; 
for example, atopic individuals have decreased capacity to be sensitised to common 
allergens. This effect probably resides within the T cell. The balance between 
sensitisation and suppression on exposure to antigen undoubtedly results most 
frequently in the latter effect; otherwise, allergic contact dermatitis would be a much 
more common problem. Such downregulation is certainly necessary for the survival of 
humans exposed frequently to a myraid of possible environmental allergens (Rietschel et 
al. 1995c).
2.5(d) Activation of Supressor Pathways
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SUB-SECTION 2.6 OCCUPATIONAL SKIN DISEASES
2.6(a) Occupational Dermatoses
Occupational dermatoses are any abnormal conditions of the skin caused or aggravated 
by substances or processes associated with the work environment. Occupational skin 
disease is still tha most frequent of all occupational illness. As in other disciplines 
associated with occupational medicine, it is essential to think of occupational 
dermatology not just in terms of diagnosis and treatment but also from the standpoint of 
preventative medicine. The latter requires multidisciplinary approach solving industrial 
medical problems with knowledge of chemistry, physics, industrial hygiene and safety, 
industrial relations and governmental laws and regulations. Packham (1998d) offers the 
following definition:
11A clinically recognisable impairment o f the skin’s normal state due entirely or 
substantially to conditions in the workplace ”.
In many cases, the origin of the skin disease is multi-factorial and has both workplace 
and non-workplace causes. The definition given allows for this, the definition however 
does not incorporate skin penetration causing damage to internal organs (ie Systemic 
toxicity). This is a significant problem, but since there may be no apparent damage to 
the skin it cannot be considered under the heading of skin disease itself.
26
Agents directly responsible for occupational skin disorders may be divided into five 
groups;
1) Chemical
2) Mechanical
3) Physical
4) Biological
5) Botanical
Organic and inorganic chemicals account for most occupational skin disorders. All 
occupational health personnel are confronted each year by increasing number of 
chemical substances introduced into the workplace. Approximately 1.95 million 
chemicals are tested by the Chemical Abstract Registry Number system with 250,000 
chemicals added to this list annually. Very few of the estimated three hundred to five 
hundred new chemicals with commercial application each year have been subjected to 
any significant amount of toxicologic investigation. The dermatologic effects of such 
agents may go unrecognised for long periods following introduction into industrial use 
(Lucas, 1974).
Mechanical causes include, friction and trauma, pressure and fibrous glass.
Physical agents include, heat, cold, vibration, sunlight and ionising radiation.
Biological agents include, bacterial viruses, fungi parasites and anthropods which may 
attack the skin and sometimes produce systemic disease of occupational origin.
2.6(b) Direct Causes of Occupational Dermatitis
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Contact dermatitis is the most frequent cause of occupational skin diseases. Two types 
are recognised; irritant and allergic. Environmental agents that are potential antigens 
and may cause disabling ezematous allergic dermatitis pose a great occupational health 
problem. Some chemical and many plant substances as well as biological agents are 
classified as skin sensitisers. Initial skin contact with them may produce no irritation, 
but after repeated or extended exposure, some individuals will develop an allergic type 
of reaction termed sensitisation (Taylor, 1982).
Sensitisation dermatitis varies greatly from individual to individual, and the once- 
immune person may, at any time, suddenly develop an allergic reaction to a particular 
substance. This allergic reaction or sensitisation often looks like a contact dermatitis ie 
small pimples or watery blisters. Peculiar to this form of dermatitis, the skin reaction 
does not necessarily appear at the site where actual skin control occurred. The reaction 
is due to the physiochemistry of the individual, thus explaining an outbreak within the 
person, although he has worked with a product for a number of years. Once a person 
has become sensitised to any material, about the only way to prevent future occurrences, 
besides medication or desensitising by a physician, is to remove him from all future 
contact with that particular product (Anon, 1975b).
2.6(c) Sensitisers
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Packham (1998c) gives a list of those substances which have been shown to be 
sensitisers and to which workers may be exposed. This listing does not show which 
sensitisers are the most common, nor does it claim to be a comprehensive listing of all 
sensitisers.
The following list attempts to identify those substances which have been shown to be 
sensitisers and to which workers may be exposed. It does not attempt to show which 
sensitisers are the most common, nor does it claim to be a comprehensive listinig of all 
sensitisers.
/. Antimicrobial agents
Parabens, p-chloro-m-cresol, formaldehyde and formaldehyde releasers (eg Grotan BK, 
Bronopol, Dowicil 200), quaternary ammonium salts, organic mercury compounds, 
hydroxyquinolines, hexachlorophane, phenoxyethanol, chloramine, thiurams, resorcinol, 
dichlorophene, Chloracetamides, DNCB, para-tertiary-Butylphenol. Ethylenediamine, 
Irgasan, Isothazolinimes.
2. Antioxidants
Derivatives of anilines, eg. Para-phenylene-diamine (PPD), phenols, Carbamates.
2.6(d) Principal Occupational Sensitisers
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It is recommended that any perfume contained in a product should be one approved by 
IFRA (International Fragrance Association). Many perfumes can be sensitisers, even in 
minute quantities.
4. Colophony
Different types of colophony exhibit different sensitising potential, depending upon their 
source and the degree of refining that has taken place.
5 Metals
Nickel and chrome are the two most common sensitisers, but others may occasionally 
sensitize. Nickel is probably the most common sensitiser of all, largely due to the level 
of exposure that occurs, particularly among women.
6. Medicaments
Many medicaments contain chemicals that can sensitise however, these are unlikely to be 
occupational unless the worker is employed in a factory producing such products.
7. Organic dyes
Most of the organic dyes known to be sensitisers are aniline derivatives. They occur in 
textiles, shoes, rubber, plastics etc.
3 Perfumes
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8. Pesticides (see also Fungicides)
A wide range of substances contained in pesticides are known to sensitise. In view of 
their potential toxicity, contact between the skin and all pesticides should be avoided.
9. Photographic chemicals
Many of the chemicals contained in photographic chemicals are sensitisers. As a general 
rule, contact should be avoided through the use of gloves and appropriate applicators.
10. Plants and Woods
Many plants are sensitisers. The most common are probably those of the primula family. 
Many woods, particularly tropical hardwoods, contain substances that may sensitise.
11. Plastics
Many plastics contain substances such as methacrylates. Many of these are known to be 
potent sensitisers. Epoxy and phenolic and polyester resins are notorious for sensitising 
effect of these substances remains for several days, even after the resin has set.
12. Rubber compounds
Natural rubber contains proteins which may cause contact urticaria. It also contains a 
range of additives (such as thiurams, mercaptobenzothiazoles, carbamates) known to be 
sensitisers. Items which may sensitise are gloves, shoes, rubber handles on tools, rubber 
tyres and fan belts etc. With gloves, good manufacturers take considerable care to
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reduce the amount of the sensitising substances to an absolute minimum “Cheap”
gloves, by comparison, may contain very high levels and lead to sensitisation.
13. Tars
Coal tar, creosote, asphalt etc.. can all sensitise. Creosote is particularly hazardous on 
the skin if exposed to UV radiation (sunlight).
14. Turpentine
Oil of turpentine can sensitise. The probability of a reaction will depend upon the origin 
o f the turpintine.
15. Wood preservatives
The main problem is creosote, particularly when applied in sunny conditions, but many 
other preservatives for wood contain substances capable of sensitising.
16. Alcohols
Some types of alcohol may sensitise.
17. Benzoyl peroxide 
Used as a flour improver.
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18. Foods
These are more likely to result in an urticarial reaction, but sensitisation does occur from 
time to time.
19. Organic silicones
These are sometimes used in so-called “barrier creams”. They are also found in 
specialised lubricants used in industry.
20. Glues, adhesives and sealants
These are frequently based on methacrylates and often cause sensitisation.
21. Lanolin
Whilst many people can use lanolin successfully as an excellent product for skin 
conditioning, there is a number of people who will become sensitised and who should 
therefore select skin creams etc. not containing this substance.
22. Metalworking fluids
The most common problem with these is irritant contact dermatitis from the degreasing 
effect of the fluid. The second most common problem is allergic contact dermatitis to 
the biocides in the fluid. These are usually formaldehyde releasers. Other ingredients, 
eg. The corrosion inhibitors and extreme pressure additives can occasionally sensitise.
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The same comments apply as for fungicides and pesticides. Almost all the known 
biocides will damage the skin, many are potent sensitisers.
SUB-SECTION 2.7 CLASSIFICATION OF SKIN SENSITISERS
2.7(a) European legislation in the classification of skin sensitisers
In the 1960’s the national provisions of the six member states on chemicals differed 
widely and thus hindered Community trade. It was recognised that there was a need to 
ensure the protection of public health, in particular the health of workers handling 
dangerous substances. This resulted in the adoption of Directive 67/548/EEC in 1967 to 
approximate the national provisions relating to dangerous substances.
EC Directive 67/548/EEC (European Council, 1967)
The Directive introduced common provisions for :
• The classification of dangerous substances, since placing a substance into one or 
several defined classes of danger characterises the type and severity o f the adverse 
effects that the substance can cause.
• The packaging of dangerous substances, since adequate packaging protects from the 
unknown danger(s) of a substance
23 . Biocides
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• The labelling of dangerous substances , since the label on the packaging informs 
about the nature of the danger(s) of the substance inside and about the safety 
measures to apply during handling and use.
The 6th amendment to the Directive 67/548/EEC adopted in 1979 introduced the 
notification systems for ‘new’ substances and consequently required the establishment of 
the list of ‘existing’ substances. EINECS, the European Inventory of Existing 
Commercial Chemical Substances (European Commission Communication, 1990) lists 
all substances that were reported to be on the market on or before 18th September 1981. 
The substances placed on the market for the first time after this target date are ‘new’.
The presence of a substance in the European List o f Notified Chemical Substances 
(ELINCS) does not authorise any new importer and/or manufacturer placing it on the 
community market from notifying it in accordance with Directive 79/83/EEC. However 
if the substance has already been notified, the competent authority may accept that the 
new notifier refer, as far as the technical dossier is concerned, to the results o f studies 
carried out by a previous notifier or notification, with his or their written agreement. 
This is in particular to avoid as far as possible the repetition of tests using vertebrate 
animals. In accordance with Decision 85/71/EEC the classification o f these substances 
is included in ELINCS only if it has been officially adopted at community level and 
therefore appears in Annex 1 to the Directive.
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In Annex 1 to the Directive 79/831/EEC the section relating to classification is only 
present if the substance has been officially classified at community level. Where the 
substance has not been officially classified at community level but has been provisionally 
classified by the notifier, an asterisk is placed in the classification section. Where the 
substance has not been provisionally classified by the notifier and no decision has yet 
been taken to classify it or not classify it at community level, the classification section is 
not present for the substance in question (European Commission, 1994).
The 7th amendment of the 67/548/EEC Directive ,(EC Directive 93/67/EEC) of 1992 
essentially required that the principles of risk assessment for ‘new’ substances be laid 
down. It further introduced the ‘sole representative’ in the notification system, and 
added the Safety Data Sheet as a hazard communication facility for the professional 
user.
Currently there are fifteen classes of danger in Directive 67/548/EEC, such as 
‘explosive’, ‘very toxic’, ‘carcinogenic’, or ‘dangerous for the environment’. The EU 
Directive (67/548/EEC) offers the following definitions o f substances and preparations;
Substances ‘chemical elements and their compounds in the natural state or obtained 
by any production process, including any additive necessary to preserve the stability o f  
the products and any impurity deriving from the process used, but seperated without 
affecting the stability o f the substance or changing its composition
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Preparations ‘'mixtures or solutions composed o f two or more substances ’
(European Council, 1996).
The Directive 67/548/EEC also includes a list of substances classified as dangerous in 
Annex 1, danger symbols (such as skull with crossed bones underneath) in Annex 11, 
standard phrases on the nature of special risks from substances (R-phrases) in Annex 
111 and the wording of safety precautions phrases (S-phrases) relating to the handling 
and use of dangerous substances in Annex IV. Annex V contains testing methods to 
determine the dangerous properties of substances, Annex VI provides detailed criteria 
on the proper choice of the class of danger and how to assign the danger symbols, R- 
and S- phrases to a tested substance. Annexes V I1 and V I11 relate to the notification 
of ‘new’ substances. Annex IX includes provision on child proof fastenings and tactile 
warning devices as special packaging and labelling elements.
The Directive is permanently updated to take into account of the scientific and technical 
progress in the field of dangerous substances. Until today it has been amended 8 times 
and adapted to technical progress 24 times.
2.7(b) Criteria for Classification of substances
Classification of chemicals in order to identify their adverse properties has been taking 
place in a number of governmental and scientific bodies throughout the world. Efforts 
to harmonise the criteria for classification of substances has been initiated. At the UN 
conference in RIO in 1992 (United Nations, 1992) there was a commitment of
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participants to work toward a globed harmonisation of classification systems. The World 
Health Organisation (WHO) regional office for Europe in comprehension of this 
agreement is working to develop a system for classification of allergens that is 
compatible with existing regulation trends. The Organisation for Econmic Co-operation 
and Development (OECD) has been designated as the co-ordinating body to achieve the 
harmonisation of classification systems relating to toxicological properties of sensitising 
substances.
One of the widely used rules for classification in the OECD is the European Union (EU) 
legislation. The various effects of chemicals can be divided into various categories of 
danger. Among these, sensitising substances and preparations can be defined as;
‘ Substances and preparations which, i f  they are inhaled or i f  they penetrate the skin are 
capable o f eliciting a reaction o f hypersensitisation such that a further exposure to the 
substance or preparation, characteristic adverse effects are produced’ (European 
Council, 1996).
When classifying sensitisers, the criteria of the directive are applied. The following is a 
draft o f the EU criteria for the classification of Skin Sensitisers, 1997.
There is sensitisation by skin contact :
(i) If practical experience shows the substance or preparation to be capable of 
inducing sensitisation by skin contact in a substantial number of persons.
(ii) Where there are positive results from an appropriate animal test.
(iii) Substances producing signs o f immunological contact urticaria.
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Human evidence would include;
a) Positive data from appropriate patch testing normally in more than one 
dermatological clinic.
b) Epideminological studies showing allergic contact dermatitis caused by the substance 
(situations in which a high proportion of those exposed exhibit characteristic 
symptoms are looked at with special concern, even if the number of cases is small.
c) Positive data from experimental studies in man. If evidence is available to 
demonstrate in practice that the toxic effect of substances and preparations, on man 
is or is likely to be, different from that suggested by the experimental results 
obtained in animal tests or by the application of concentration limits for classification 
of preparations , then such substances and preparations should be classified 
according to their toxicity in man. However, tests on man should be discouraged 
and should not normally be used to negate positive animal data.
A substance may be classified as a skin sensitiser when there is supportive evidence such
as:
a) Isolated episodes of allergic contact dermatitis or
b) Epidemiological studies where chance, bias or confounders have not been ruled out 
fully with reasonable confidence.
This supportive evidence may include, data from animal tests performed according to
existing guidelines, with a result that does not meet the criteria given in the section on
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animal studies but is sufficiently close to the limit to be considered significant, or data 
from non-standard methods or appropriate structure -  activity relationships.
Animal studies used to classify substances as Skin Sensitisers would include positive 
results obtained from appropriate animal tests. In the case of the adjuvant type test 
method for skin sensitisation, detailed in the test methods described in Directive 
(67/548/EEC, Annex V) a response of at least 30% of the animals in the Guinea Pig 
Maximisation test is considered as positive, and for any other test method a response of 
at least 15 % of the animals is considered positive (Tobiassen, 1997)
The Swedish Chemicals Inspectorate, in its capacity of rapporteur to the Harmonisation 
Advisory Body under OECD, produced a draft summary review of the criteria used in 
the OECD member states for the classification of sensitisers. They concluded that the 
various member states only differed on minor points from the EU criteria described 
above. Some of the countries outside the EU apply similar criteria including Australia, 
Norway and Switzerland.
According to the Swedish report, classification of sensitisers in Canada are also close to 
the EU criteria, although the focus is more specifically on evidence from the workplace. 
In the United States, several agencies are involved in the regulation of chemicals. The 
criteria addressing sensitisation have many points in common with the EU criteria and 
use clinical pictures of sensitisation when describing the effects (Organisation for 
Economic Co-operation and Development, 1996).
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In January 1996, in Copenhagen, Denmark, the WHO regional office for Europe and the 
National Institute of Occupational Health, Copenhagen, Denmark, organised a working 
group on criteria for classifying skin substances in the work and general environments 
with invited international experts. The meeting was co-sponsored by the Nordic Council 
of Ministers and the Swedish Building Research Council. The participants reached a 
consensus on criteria to identify and classify significant skin sensitisers. Evidence 
relevant for classifying substances was grouped as human, animal and other. Significant 
skin sensitisers were classified into four classes. The classification principle corresponds 
to the criteria for carcinogens of the International Agency for Research on Cancer.
For skin sensitisers, a classification scheme was developed for categorising substances as 
significant contact allergens (Class I) and probably significant allergens (Class II). Class 
III was designated as substances non classifiable. Class IV, not a significant contact 
allergen was used if many people have been extensively exposed to the substance for a 
long time, but contact allergy is extremely rare. It was recommended that the proposed 
criteria be adopted by member governments (Anon, 1997a).
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Table No.l Classification Scheme for Skin Sensitisers (WHO, 1996)
Class Human Evidence Animal Evidence Other Evidence
L
Significant 
Contact allergan
Sufficient 
evidence present
Evidence may be 
present or absent.
Evidence may be 
present or absent.
Limited evidence present Sufficient 
evidence present.
Evidence may be 
present or absent
II.
Probably
a significant contact 
allergan
Inadequate 
evidence present
Sufficient 
evidence present.
Evidence may be 
present or absent
Limited evidence present
Limited evidence present Evidence present
III
Not Classifiable All other All other possible combinations, but see Class IV 
below.
IV
Not a significant 
contact allergan
Many people have been extensively exposed to the substance for a long time, but 
contact allergy is extremely rare.
With regard to the classification scheme above the following terms are used:
Significant contact allerean refers to:.. . . ^ m1  . 1 . 1 « I .„ I I I  fcl  II ■ I I
Substances which are (presumed) capable of causing more than isolated cases of allergic 
contact reactions.
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Sufficient evidence refers to:
(i) Epidemiological studies and/or studies in consecutive skin tested patients
conducted in accordance with well established principles which demonstrate an 
association between exposure and the clinical evaluation of dermatitis/contact 
urticaria, including positive skin tests.
(ii) The substance is found to cause contact sensitisation in at least two separate
animal studies (at least one of which must be in the guineapig) -  the contact 
sensitising capacity should be statistically significant in comparison with non­
sensitised control animals.
Limited evidence refers to:
(i) Isolated cases of allergic contact reactions demonstrated by properly
conducted skin tests in the presence of relevant exposure and in more than one 
independent centre.
(ii) Where the substance is found to have contact sensitising ability in one OECD 
test method. The contact sensitising capacity should be statistically significant in 
comparison with non-sensitised control animals.
Inadequate evidence refers to:
Where individual cases of allergic contact reactions demonstrated by skin tests in which
the requirement for limited evidence is not satisfied (WHO, 1996).
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In Ireland, the control on importation of substances is largely on the onus of the 
Revenue Commissioners who operate a tariff code system that groups chemicals into 
broad categories. It is not possible to identify individual chemicals, hence information 
relating to the volume of substances classified as skin sensitisers, which are imported 
into Ireland on an annual basis is currently unavailable.
The Health and Safety Authority is the sole representative in the notification system for 
substances and preparations in Ireland in accordance with Council Directive 92/93/EEC. 
As the NONs authority in Ireland, the H.S.A. has a record of the new chemicals 
classified as skin sensitisers that have been brought into the country since the notification 
scheme started in 1982. The precise figures on the quantities is not available, also there 
are no records of imports o f ‘existing’ substances classified as skin sensitisers. There are 
three thousand, seven hundred chemicals that can cause allergic contact dermatitis (De 
Groot, 1994) and data on new ones are published every year
44
SUB-SECTION 2.8 VARIABLES IN OCCUPATIONAL SKIN EXPOSURE
2.8 Evaluation of dermal absorption
The variables which are critical in the evaluation of dermal absorption in the workplace 
are:
• Form of the chemical.
• Duration of dermal exposure.
• Exposed area (size as well as location on the body).
• Presence of other chemicals (mixtures constituent dispersant).
• Workload and environmental factors (humidity and temperature).
(i) Form of Chemical
In an industrial setting dermal absorption can result from exposure to vapours or from 
skin contact with liquid chemicals or their solutions. Dermal absorption of gases and 
vapours of volatile chemicals is usually negligible compared to pulmonary absorption 
(Riihimaki etal. 1978). However, the vapours of chemicals with low vapour pressure, 
such as furfural (Flek et al. 1978) or chemicals with high aqueous solubility, such as 
methanol (Sedivec et al. 1981) can condense on the body surface, and consequently 
their availability for dermal penetration can be increased. Dermal penetration of solids 
(dust, aerosols, etc) can be facilitated by their dissolution in pespiration.
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While the surface area of skin exposed to vapours and gases is the same as the whole 
body surface area of skin exposed to aerosols, dust and liquids is difficult to estimate. 
Protective apparel can reduce the exposed area, but contaminated, dirty apparel can 
enhance the chemical availability for dermal absorption (Trojanowska, 1959). Spills can 
result in an unpredictable dermal exposure of a large body surface. Moreover, the 
thickness of the layers of skin cells on different parts of the body varies so that the 
penetration rate varies (Scheuplein and Bronaugh, 1983).
(Hi) Presence of other chemicals
Studies with drugs have proved that absorption and therapeutic effects depend on the 
vehicle by which the drug is administered (Cooper, 1985). The same applies to 
industrial chemicals. Dermal contact with a mixture of chemicals can alter the 
penetration rate by two mechanisms;
1) The penetration may be slowed down if the chemical is readily soluble in the 
dispersant.
2) Biochemical and skin permeability changes may occur in the skin as a result of 
prolonged contact with liquids. If the dispersant damages the skin, then the 
penetration rate of mixture components is expected to increase.
(ii) Exposed area o f the Skin
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Since the dermal absorption depends on blood perfusion of the dermis and hypodermis 
under the exposed area the absorption rate increases with movement and ambient 
temperature; this means that increased workload and heat enhance dermal absorption 
(Dutkiewicz et al. 1961; Fiserova-Bergerova, 1990).
SUB-SECTION 2.9 PREDISPOSING FACTORS FOR SKIN DISEASES 
2.9(a) Predisposing Factors in Occupational Skin Disease
Predisposing factors for occupational skin disease as a subject appears to take a back 
seat to history and therapy when occupational physicians are confronted with a patient 
with a work related disease. Encompassing all occupational skin disease cases, the 
affected workers who emerge as cases from a population of many workers do not do so 
randomly. Certain factors related to the workplace and certain factors intrinsic to the 
employees have to be present that, when combined, result in a work related disease. It 
os important to isolate and examine these special host and environmental factors as a 
specific area.
2.9(b) Job-related factors
There are ways in which job-related factors predispose to the development of 
occupational skin diseases. The one most direct involves the actual work environment. 
Job-related pre-disposing factors for occupational dermatoses that are unique to the
(iv) Workload and Environmental Factors
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workplace or task include the following; wet work, irritating chemicals and allergens,
heat, cold, humidity, vibration and radiation.
a. Wet work looms as one of the most ubiquitous workplace factors, but oddly enough 
receives little attention (Orris et al. 1982). While singling out more obvious irritants 
and allergens, water as an irritant is often overlooked. In clinical practice, one is 
struck by the preponderance of skin problems among workers whose jobs involve 
intermittent water exposure (Lammintausta, 1981).
b. Irritating chemicals in the workplace are well known and thus usually considered in 
the evaluation of work-related dermatitis. The irritants themselves may often be a 
mixture, including solvents, soaps, detergents, plant juices, antioxidants, acids, 
alkalis, reducing agents, cutting oils and many more
c. Allergens are chemicals that provoke specific delayed hypersensitivity. Although 
each industry has its own set of common potential allergens, certain chemicals are 
ubiquitous enough or are potent enough sensitisers to be frequent offenders.
d. Heat, cold, humidity, radiation and vibration are important physical and mechanical 
environmental factors that may contribute to the effect of chemical agents.
e Workers in certain outdoor industries namely forestry, agriculture, fishing and food 
processing have significant problems associated with mites, plants, bites, zoonotic 
mycors and viruses.
f. As a predisposing cause of occupational skin disease, trauma on a micro scale may 
figure importantly. For example, machinists have ample opportunity to develop
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minute cuts in addition to chemical exposures. Similar micro trauma plays a role in 
the inoculation of pathogens in industries with biohazards (Marks et al. 1997b).
2.9(c) Host Related Predisposing factors
Host related factors are of two types, those that represent variation within normal but 
that still predispose to work-related disease, and those that are abnormal enough to be 
considered clinical skin disease and that can flare under certain conditions or predispose 
to other work-related disease.
Host variations are usually not enough to cause work-related disease, however. Where 
job-related factors and host variation heighten the vulnerabilities of the employee’s skin, 
then the possibility that a work-related skin disease will result is increased.
• individuals with dry skin fare poorly in work environments involving solvents, soap, 
detergents and intermittant water exposures. These workers can easily develop hand 
eczema if their hands are exposed long term to chemicals in a work environment.
• The resistance to skin disease decreases with age. Clinical dermatitis may seem less 
reactive at first, but both allergic and irritant eruptions tend to persist and to be more 
resistant to therapy in aging skin (Fischer, 1986).
• Greater degrees of hairiness have been cited as a predisposing factor in the 
development of falliculitis, and it would appear that follicles bearing large terminal 
hairs in areas of friction, sweating, and oil exposures would be predisposing to 
follicular irritation (Cohen, 1982).
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Sweating serves a crucial role in many aspects of occupational skin diseases, and 
individuals who are hyperhidrotic may be relatively predisposed. Sweating may place 
in solution potential allergens and transport them to the skin, where if drying does not 
occurt, percutaneous penetration is enhanced by the occlusive environmental set up 
by this process.
The rate of existing skin disease in the development of other work-related skin 
disease is very important and may result in reasonable intervention at the job 
applicant stage. Some intercurrent skin diseases are, atopic eczema, acne, psoriasis 
and cutaneous allergies. Atopic skin is uniquely vulnerable to dermatitis because of 
its diminished threshold for irritation (Rajka, 1975).
Individuals who are acne prone, are predisposed to aggravation of acne under work- 
related conditions (Ancoma, 1986).
Psoriasis being a common dermatalogic disorder in general, may be of particular 
significance in terms of occupational aggravation.
Cutaneous allergies can be an important predisposing host factor, particularly if the 
allergen is a ubiquitous one and if the degree of sensitivity to the substance is great. 
Individuals allergic to chromate are a good example, and it is hard to find work 
environments free of chromates that would not aggravate an individual who is very 
sensitive. A person who is allergic to one substance is not necessarily more likely to 
become allergic to other dissimilar substance than one who is not allergic at all, 
therefore monoallergy does no predispose to polyallergy (Fischer, 1986b).
Awaremess of certain predisposing factors, by employers and employees should have a 
significant impact on work-related skin diseases and the role of the dermatologist in 
providing this information is essential (Fischer, 1986a).
2.9(d) The Diagnosis of Contact Dermatitis - Patch Testing
Contact sensitisation is never hereditary but a consequence of earlier exposure to a 
chemical. In humans contact sensitisation is diagnosed by a positive patch test 
performed with correct technology. The inflammatory skin disease, allergic contact 
dermatitis may occur when contact sensitised individuals are exposed to the specific 
chemical.
Patch testing is an essential tool that used to established the diagnosis of allergic contact 
dermatitis. The patch test was introduced in 1896 by the Swiss dermatologist 
Jadahsson. In 1931 Sulzberger and Wise formally introduced patch testing to the 
American dermatologie community. It is a biological test where contact sensitisation is 
proved by re-exposing the individual on a 0.5-lcm2 large skin area. This procedure 
involves placing a small amount of each of the suspect substances in a suitable 
‘vechicle’, usually petrolatum, in a small aluminium or plastic cup attached to sticking 
plaster. The series of cups are then placed on the skin, usually on the back and left there 
for 48 hours.
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When the plaster is removed the dermatologist will examine the skin to ascertain which 
substances have provoked a reaction. Patch testing is a highly skilled art. The dilution 
of the substance for testing must be enough to trigger an allergic reaction should the 
patient be sensitised, but not elicit an irritant one due to the length of contact and the 
occlusion. Intrepreting the various red inflammed blotches on the skin requires 
knowledge and experience. Patch testing will only indicate the presence of an existing 
sensitisation it is absolutely no use in determining who will or might become sensitised 
(Rietschel, 1995b).
This test system is a valuable practical tool for the dermatologist. Standardisation has 
taken place since its introduction, first by the Scandinavian group for standardisation of 
Patch Testing and later by the International Contact Dermatitis Research Group 
(ICDRG). The patch test is particularly valuable in ascertaining the cause of outbreaks 
of isolated cases of allergic contact dermatitis in an industry where workers are directly 
or indirectly exposed to many sensitising chemicals. Although a careful history and 
personal investigation of the patient’s exposure to contactants often reduce the necessity 
for routine patch tests such procedures are often necessary to confirm a diagnosis of 
allergic contact dermatitis.
Patch testing may help in differentiating occupational and non-occupational dermatitis, 
particularly when a person with contact dermatitis is exposed to sensitisers not only at 
work but also at play or in persuit of hobbies. Properly performed patch testing may 
pinpoint the offending contactant quickly and efficiently whereas reliance on history and
trial may prolong the dermatitis while the offending allergen is been persued, (Marks, 
1997c).
Contact allergy can be quantified by the degree of positive patch tests, by patch testing 
with graded concentrations and by experimental use testing. The individual patch test is 
graded according to internationally agreed scoring system. A useful scoring system is 
that used by the North American Contact Dermatitis Group and is referred to as the 
patch test reading morphology codes. This system allows for a four point positive 
reading scale of +/-, +, ++, and +++. A +/- is a questionable reaction; with a definite 
positive reaction (erythema with edema or papules) being marked +; ++ indicates a 
strong edematous or vesicular reaction and +++ extreme spreading bullous or ulcerated 
responses (Plates 1-8). A negative reaction is coded with -. In addition, the system 
allows for an irritant morphology reading (IRR). This would be seen as a glazed or 
‘burned’ appearance or pulsutor or purpuric reactions ( Appendix A), (Marks, 1997c).
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SUB-SECTION 2.10 PROGNOSIS OF OCCUPATIONAL DERMATITIS
2.10(a) Prognosis of Occupational Dermatitis Cases
Persistance of dermatitis after avoidance of primary contactants is well known. 
Prognosis in contact dermatitis refers to the outcome of dermatitis over time, with and 
without intervention. Understanding the prognosis of contact dermatitis enables the 
dermatologists to forecast probable outcome of the dermatitis to patients. Long term 
outcome of contact dermatitis especially occupational contact dermatitis, has important 
medicolegal implications. Prognosis of dermatitis helps dermatologists and employers to 
implement risk management of patients who are exposed to potential irritants and 
allergens, and hence plan preventative measures against contact dermatitis.
The prognosis of patients with contact dermatitis following secondary preventative 
measures refers to those patients who were confirmed to have contact dermatitis based 
on clinical findings and those who had received councelling on avoidance of contactants 
and on preventative measures. There is an association of prognosis outcome with risk 
factors including atopy, age, job change, contactants (irritants and allergens), and 
occupation.
2.10(b) Earlier reports on the prognosis of contact dermatitis
Earlier reports on the prognosis of contact dermatitis (especially occupational 
dermatitis) documented poor prognosis for total clearance of dermatitis. Burrows in
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1972 reported that 79% of patients who were followed up over 1 0 - 1 3  years, still 
required treatment for their contact dermatitis.
A. Prognosis -  Age
The age of onset of contact dermatitis does not appear to influence its prognosis as 
Burrows reported no significant difference in the prognosis between patients of < 40 
years old and those > 40 years old (dermatitis clearance rate was 15% versus 16% 
respectively) followed up over 10 - 13 years. Chromate allergy from cement is 
associated with poor prognosis and Burrows reported that only 8% of patients with 
cement dermatitis had clearance of dermatitis after 10-13 years follow-up.
B. Prognosis -  Job Change
With regard to prognosis and job change earlier reports indicated that job change was 
not associated with significant improvement in the prognosis of occupational contact 
dermatitis. Burrows reported that only 20% of workers with dermatitis had stopped 
working when followed up over 10- 13  years. Among these workers, only 18% had 
clearance of their dermatitis.
2.10(c) Recent reports on the prognosis of contact dermatitis
Recent reports have indicated that present prognosis is much better (Chia et al. 1991, 
Rosen et al. 1993, Nethercott et al 1994). Reports between 1961 and 1972 (Burrows 
1972, Skog et al. 1961) documented the prognosis for total clearance ranging from 8% 
to 33%. Reports after 1990 documented a clearance rate of about 70%. In Singapore,
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total clearance of dermatitis after one year of follow-up of patients with occupational 
dermatitis was 72% with slightly better prognosis for patients with allergic contact 
dermatitis (77%) than irritant contact dermtitis (70%) (Chia et al. 1991).
In Sydney, Rosen et al. 1993, reported total clearance of dermatitis in 38% of patients 
with allergic contact dermatitis and 30% for patients with irritant contact dermatitis over 
a two to three year follow-up period. However, if patients who reported improvement 
were included as a favourable prognosis, then the rates were 74% and 68% respectively. 
In the United States, Nethercott et al. 1994, reported clearance in 63% of patients with 
occupational contact dermatitis followed up over four years. When patients with mild 
eczema were included, the improvement rate was 81%. There were more workers with 
allergic contact dermatitis who reported that they were free of dermatitis than irritant 
dermatitis in the study.
A. Prognosis - Age and Sex
Chia et al. 1991, reported a slight improvement in prognosis in the older patients (>39 
years old) with clearance rate of 85% compared with those of younger patients with a 
clearance rate of 65%. Nethercott et al. 1994, did not find any difference in prognosis 
among patients with contact dermatitis among age groups. Most reports showed that 
there was no significant difference in the prognosis of patients with contact dermatitis 
between males and females. In Singapore, the prognosis of male patients with allergic 
contact dermatitis (clearance rate of 90%) was significantly better than females 
(clearance rate of 50%). There was no significant difference in the clearance rate of
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irritant contact dermatitis between male and female patients (Chia et al. 1991). 
Similarly, Nethercott et al. 1994, reported no significant difference in the prognosis of 
males and females with occupational contact dermatitis followed up over two years 
(with clearance rates of 60% for males and 75% for females). Chia et al. 1991, reported 
that the overall prognosis from occupational allergic contact dermatitis was good with 
77% of their patients reporting total clearance of dermatitis. However, patients with 
metal allergy eg, nickel and cobalt, had a poor prognosis. 75% of patients with metal 
allergy had persistent dermatitis despite ‘avoidance’ of metals. The chronicity in contact 
allergy to these allergens is associated with their ubiquity and the fact that daily 
avoidance of these allergens is almost impossible.
In contrast to earlier reports (Burrows, 1972), the prognosis of patients with chromate 
dermatitis in Singapore was reported to be good. All five patients with chromate allergy 
had clearance of dermatitis upon avoidance of chromate (Chia et al. 1991).
B. Prognosis - Job Change
With regard to prognosis and job change, the prognosis for patients with contact 
dermatitis (irritant and allergic) who stopped being exposed to the contact irritants and 
allergens were slightly better than in those who continued. The overall clearance rates 
for patients who stopped were 73% compared to 69% for those who continued. The 
corresponding rates for allergic contact dermatitis were 71% for workers who stopped 
and 74% for those who continued, and for those with irritant contact dermatitis the rates 
were 74% and 68% respectively (Chia et al. 1991). In Sydney the prognosis was
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significantly poorer in patients who continued to work (clearance rate 28%) compared 
to those who changed jobs (clearance rate 43%) (Rosen et al. 1993).
C- Prognosis - Atopy
A personal history of atopy also appeared to significantly affect the prognosis of patients 
with occupational contact dermatitis. Rosen et al. 1993, reported that the clearance 
rates in patients with atopy (30%) were significantly poorer than those in workers 
without atopy (41%). In contrast, Nethercott and Holness, 1994, did not report any 
significant difference in prognosis between atopies and nonatopic workers with 
occupational dermatitis. The clearance rates were 59% and 65% respectively.
Overall, there are numerous factors that influence the outcome of contact dermatitis. 
Patients with allergic contact dermatitis, (with the exception of chromate allergy), 
appear to have slighter better prognosis than patients with irritant contact dermatitis. In 
allergic contact dermatitis, a specific contact allergen can often be identified and patients 
are advised to avoid it. Risk factors include the present and past history of eczema and 
atopy. Job change tends to improve outcome but many continued to have dermatitis 
after changing (Chia et al. 1991, Burrows, 1972, Rosen et al. 1993 and Nethercott et al. 
1994).
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SUB-SECTION 2.11 CONTACT DERMATITIS AND WORKERS
COMPENSATION
2.11 (a) Workers Compensation Laws
Worker’s compensation laws were and important development of the industrial 
revolution. They provided a satisfactory means of handling occupational disabilities as 
the economy evolved from being predominantly agricultural to industrial. These laws 
were first enacted in Germany in 1884, followed by Great Britain in 1897, the United 
States in 1911 and Canada in 1915.
Before workers’ compensation laws, the employee or the survivor according to common 
law principle sued the employer for damages that were due to employer negligence. 
This was a slow, costly, uncertain legal process that put the employee at a great 
disadvantage. Thus the essence of the workers’ compensation laws that were enacted 
entitled the employee to medical treatment and compensation without regard to any fault 
and held that the employer should assume the cost of occupational disabilities. The 
workers’ compensation statutes vary from country to country and various individuals 
become involved with these laws; the employer, the employee, insurance agents, 
attorneys, physicians and administrators of the law.
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1) Regardless of fault, provide occupationally induced illness or accident victims with a 
sure, prompt, reasonable income and medical benefits.
2) Reduce lengthy and costly court action.
3) Relieve public and private financial drains, since workers compensation is paid for by 
the employer.
4) Encourage employer interest in safety and rehabilitation of the worker.
5) Promote investigation of the causes of accidents and disease, which will, it is hoped, 
reduce human suffering.
A principal element of workers’ compensation is to show that the injury or illness has an
occupational causation and, in addition, to determine to what extent and for how long
the worker is disabled.
The physician plavs an important role in workers’ compensation and this includes:
1) Providing care for the injured or diseased workers
2) Evaluating the relationship to work
3) Determining the degree and the period of disability and
4) Providing advice to the worker and industry about rehabilitation and peventative 
measures (Ross, 1994).
Workers’ compensation laws should meet the following objectives;
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Establishing a casual relationship between work and skin conditions is one of the areas 
that seem to cause most difficulty for the physician. Mathias (1989) very clearly 
outlined the criteria for establishing occupational causation and aggravation. He 
suggested seven criteria that should be present before the clinician conclude that the 
dermatitis was occupationally induced. Any criterion that was answered negatively 
suggested that the dermatitis may not be work related (Appendix B).
Together these criteria form a logical uniform basis for assessing the probability of 
causation from workplace exposures. Because workers’ compensation law requires that 
there be only reasonable probability (more than 50% likelihood) of causation, the answer 
to at least four of the criteria should be “yes” before the clinician concludes that 
dermatitis probably was caused by a workplace exposure. If four or more of the criteria 
cannot be answered affirmatively, a conclusion of probable occupational causation may 
be difficult to justify without further investigation (Mathias, 1989).
2.11(c) Workers Compensation in Ireland and the United Kingdom
In Ireland and the United Kingdom, employers pay into the Industrial Injuries Scheme 
(Pay Related Social Insurance), and contribute until their retirement. The work injury 
benefits are part of the national security system of the country. Industrial diseases are 
tabulated in schedules due to cause. Doctors determine if the applicant is suffering from 
a defined illness and they determine the extent of the disability and the estimate how 
long it will last. A percentage rating is then made. The award that is decided on the
2.11(b) Work and Skin Conditions
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basis of medical recommendation is purely an impairment award and is independent of 
other losses of earnings which are covered by other parts of the Irish (British) Insurance 
program (Health and Safety Commission, 1997/98, Health and Safety Authority, 1997).
SUB-SECTION 2.12 DATA GATHERING ON OCCUPATIONAL SKIN 
DISEASE.
2.12(a) Methods used for data gathering
Contact dermatitis caused by allergens is the most important allergic skin disease related 
to occupation. A number of methods are utilised to correlate data from the incidence of 
skin diseases.
* Surveillance is the ‘ongoing scrutiny, generally using methods distinguished by their 
practicability, uniformity, and frequently their rapidity rather than by complete accuracy. 
Its main purpose is to detect changes in trend or distribution in order to initiate 
investigative or control measures.
*A register is a ‘file of data, collected for a specific public health purpose containing all 
(identifiable) cases of a particular disease or other health relevant condition, in a defined 
population such that the cases can be related to a population base’. With this 
information, incidence rates can be calculated.
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^Epidemiology may be defined as ‘the study of the distribution and determinants of 
health related states or events in specified populations, and the application of this study 
to control of health problems (Last, 1988).
2.12(b) Incidence and prevelance
Incidence and prevalence are measures of disease frequency. The frequency is expressed 
as a rate i.e. Number of cases per number of persons in the group within which the 
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during the whole period of observation), whereas incidence density refers to a dynamic 
group - new (exposed) participants may be added during the study period, while others 
may be deleted (i.e. no longer exposed). The prevalence rate is a measurement of the 
numbers of existing disease in a population at one point in time (Kramer, 1988).
There are various reasons to favour prevalence rates rather than incidence rates in 
studies of skin allergy. Allergic contact dermatitis is a non-fatal, chronic disease. Even 
with low incidence rates the prevalence may be high the new cases being added to an 
already high basic rate. Incidence rates can be calculated only for the disease, not for 
sensitisations, since the exposure which led to sensitisation may be different from the 
exposure, which led to elicitation. Prevalance rates can be applied both to sensitisation 
rate to a certain allergen and to the manifest disease, allergic contact dermatitis.
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Passive data generation occurs when people consult a physician because they suffer from 
contact dermatitis. Clinical examination and patch testing would provide the diagnosis 
(allergic contact dermatitis) and the cause of the illness (sensitisation to an allergen). 
Thus, passive data generation is the basis of morbidity statistics. Registers of 
occupational skin diseases are kept in several European countries and in the United 
Kingdom (Mathias, 1988, O’ Malley, 1988, Roche, 1993). Most of the registers contain 
data on all type of skin disease and no distinction is made with regard to the type of 
disease (irritant or contact dermatitis).
The most important data source on occupational allergic skin diseases is the statistics 
generated by dermatologists. Dermatologists record the patient’s history, (e.g. 
occupation), examines the case clinically (including constitutional risk factors) and uses 
patch testing to make the allergic diagnosis. Until recently, this data was used only 
sporadically for evaluation purposes. In the United Kingdom, dermatologists from 
sixteen centres started a pilot study in order to assess the viability of maintaining a 
surveillance register of occupational dermatitis through a simple card reporting system. 
In the first twelve months, this group has identified one thousand, four hundred and 
sixty six new cases of occupational dermatitis.
Since February, 1993, consultant dermatologists in the United Kingdom have been 
reporting to Epi-Derm the surveillance scheme for work related skin disorders. 
Occupational physicians reported to the same scheme from May 1994 to December
2.12(c) Passive data generation
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1995. Since January 1996, occupational physicians have reported skin disease along 
with other types of occupational disease to their own scheme OPRA (Occupational 
Physicians Reporting Activity).
In recent years, there have been several thousand cases per year leading to some level of 
specialist intervention. An estimated three thousand, seven hundred cases were seen by 
dermatologists and occupational physicians in the EPIDERM and OPRA surveillance 
schemes, approximately 80% of which were contact dermatitis (Beck, 1992).
The Health and Safety Commission, 1997/1998, reported that there is some indication of 
a downward trend in the number of cases of occupational dermatitis over the last five 
years from the data on disablement benefit cases, although the EPIDERM and OPRA 
data indicate a slightly increasing trend over the last four years.
2.12(d) Occupations most commonly associated with Contact Dermatitis
The occupations estimated to be the most commonly associated with contact dermatitis 
in EPIDERM / OPRA seen by dermatologists are other occupations in sales and services 
(9.0%), hairdressers and beauticians (8.4%) and health associates (7.8%). The most 
common occupations seen by occupational physicians are chemical operatives (10.4%) 
and health associates (9.3%). Those with the highest estimated rates of contact 
dermatitis among occupations in mining and manufacturing (8.9%) and hairdressers and 
beauticians (8.3%) (Health and Safety Commission, 1997/98).
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In Ireland up to 1995, the only source of data for occupational diseases was the 
Department of Social Welfare. During 1995, the basis of data collection was broadened 
to include hospital pathologists, dermatologists, chest physicians, pesticide adverse 
reaction reports, National Poisons Centre, National Cancer Registry and the Department 
of Health. Under reporting of occupational diseases is still a problem.
The Health and Safety Authority (H.S.A) compile the statistics for occupational 
diseases. The H.S.A annual report 1997 presented data relating to occupational 
dermatitis cases reported from 1994-1996 as 44, 63 and 38 respectively. The 1997 
annual report is the most current report available however, it does not distinguish 
between allergic/irritant dermatitis . With regard to the collection of data for 
occupational skin diseases, the H.S.A are currently gathering information from the 
Department of Social Welfare Occupational Injury Benefit section and direct from the 
Register of Occupational Dermatological Disease (Appendix C). A number of 
dermatologists in Ireland take part in this surveillance similar to the EPIDERM survey 
conducted in the United Kingdom (Health and Safety Authority, 1997).
2.12 (f) Statistical Information on Social Welfare services
In Ireland there are approximately fifteen thousand claims per year. In the most recent 
annual report issued by the Department of Social Welfare there were 14,774 injury 
benefit claims of which 11,169 were allowed (of those two hundred were prescribed 
diseases).
2.12(e) Data gathering for occupational skin diseases in Ireland
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Total Social Welfare expenditure in 1997 was £4,524 million, which represented 32.3% 
of net current government expenditure. The main areas of expenditure by programme 
group were old age (22.88%), widows, widowers and one parent families (17.4%), child 
related payments (9.63%), illness, disability and caring (3.0%), unemployment and 
employment supports (23.15%). In 1997 there was an expenditure of £624,185 on 
social welfare for illness, disability and caring. Of this £179,919 was spent on disability 
benefit £6,740 on injury benefit and £38,287 on disablement benefit.
The Social Welfare services deal with approximately 15,000 claims per year (10,000 
awarded) for injury benefit, 3,000 per year (2,000 awarded) for disablement benefit and 
12,000 per year (9,000 awarded) for disability. In 1997, there were 14,774 claims 
received and 11,169 were awarded.
The conditions for benefit to qualify include the following
• You must be suffering from one of the prescribed diseases. A prescribed 
occupational disease is one of the diseases listed that has developed due to the nature 
of your employment.
• You must have been employed after May 1st 1967 in one of the occupations 
prescribed in relation to that disease
• The disease must be due to the nature of the occupation.
67
Injury benefit is a weekly payment made during periods of incapacity for work as a 
result of an injury received or a disease contracted at work. Benefit is payable for a 
maximum of twenty-six weeks. The Disablement benefit is payable as a weekly or four­
weekly pension; this is normally payable after injury benefit has ceased to be payable.
SUB-SECTION 2.13 SKIN MANAGEMENT 
2.13(a) Occupational skin disease and its prevention
The optimal strategy in dealing with occupational skin disease is its prevention. This is a 
multidisciplinary endeavor that requires planning by the employer, employee, 
government officials and healthcare personnel to develop preventative measures. The 
responsibility for prevention of occupational skin diseases rests on a number of 
individuals including toxicologists, chemical and safety engineers, manufacturing 
management, industrial hygienists, workers, government regulators and scientists, and 
healthcare providers. It is the integration and co-operation among these individuals that 
prevent occupational skin disease. The ultimate aim of any skin management system 
should be to prevent all contact between any substance capable of causing damage.
According to Packham (1998), an “effective skin management is a system to ensure that 
so far as practicable, the workplace is intrinsically safe as regards damage to health 
through skin exposure. Where this is not achievable, the system will incorporate 
appropriate provisions for personal protective equipment to achieve adequate control
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o f exposure. The system is not static, but must re flect actual workplace conditions and 
adapt to changes and developments in our knowledge o f how the skin reacts to 
substances
2.13(b) Elements of a skin management system
Packham (1998) offers a structured approach to take into account the different elements 
of a skin management system.
Fig.4. Elements of a Skin Management System (Adapted from Packham,C.L, Essentials o f  
Occupational Skin Management, 1998).
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This system is designed to ensure that the risk of damage to health through skin 
exposure is kept to an absolute minimum and that any health problems that may arise are 
identified at the earliest possible stage so that remedial action can be taken.
1) Management Policy
According to Packham (1998), the policy should provide a clear and comprehensive 
statement to include information relating to what the employer is trying to achieve and 
how this is to be done. The policy sets down the objectives that are set by management 
and the responsibilities and duties of the employer, employee and any one else involved. 
The skin management policy may include the following information;
•  The purpose of the policy.
• The responsibilities of the company.
• The responsibilities of the employees.
• The methods to be used for the prevention of occupational skin problems.
• Provisions relating to training and education.
• Information and labelling for products.
• Working practice
• Health surveillance.
• The procedures to be used for reporting.
2) Education
Worker education is an integral part of occupational skin disease prevention. The 
worker should be provided with information on the toxic nature of chemicals in the
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workplace, instructions concerning the use of protective measures, and procedures to 
follow in the case of accidental exposure. According to Packham (1998), a skin 
management system should involve ‘comprehensive education and training which is 
relevant, accurate and applicable’, This means that the material contained in the 
educational programme must address the needs of that particular operation. Both 
management and workers must have the appropriate knowledge both about the 
processes and substances present in the workplace and also an understanding of the skin, 
its functions and the problems which can arise from the above.
3) Hazardous Material Identification.
The recognition of potentially hazardous chemicals should be accomplished by 
toxicologic testing before introduction into the workplace. For allergens and irritant, 
risk assessment testing can define the inherent irritant and allergenic properties of the 
chemical. This information should be found on the material safety data sheets and 
should be reviewed before new materials or processes are used.
4) Risk Assessment
Techniques for the assessment of risk to health through skin contact are poor and are 
mostly highly subjective. According to Packham (1998a), ‘Assessment o f the risk to 
health through skin exposure is complex. There are few technical aids to help us and 
no standards such as exposure limits which can act as a guide moreover, the data with 
which we have to work may be inaccurate and/or incomplete A structural approach 
will enable us to rank the many risks in the average workplace in some order of priority
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so that we can deal with the most serious potential risk first. Risk assessment is an 
ongoing process”.
Packham (1998a), approaches the measurement of risk assessment of skin disease by 
dividing the way in which exposure occurs into two groups, “ambient” and “task based”. 
A task can be defined as a discrete action or set of actions with a clear start and finish 
which can be described in such a way that it can be repeated with a considerable degree 
of accuracy. Task-based exposure, therefore is exposure that is caused directly during 
the execution of the task. Ambient exposure is all other forms of exposure (ie the 
presence in the workplace in such a way that exposure of the worker is occurring not 
specifically associated with his actual task).
Since virtually all ambient exposure will be as a result of some activity being carried out 
within the workplace, therefore it is essentially task based. Packham (1998a), provides a 
strategy for a task approach to risk assessment (see pg73). The flow chart illustrates 
one possible structured approach to risk assessment based on the individual task, but 
which also takes into account of ambient exposure, where this can be identified.
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The employer has several potential means of preventing occupational dermatoses, 
including environmental control, good housekeeping, warnings on hazardous material, 
and education of the workers. Ideally, exposure to hazardous chemicals can be 
eliminated by the engineering of closed systems that allow the manufacturing process to 
proceed without exposing the worker to harmful chemicals. Engineering systems such 
as automated samplers, computerised manufacturing, and robotic packaging may be 
implemented. Although this protects the line worker, consideration must also be given 
to maintenance personnel who may have exposure to hazardous chemicals. The goal of 
these engineering controls is to minimise cutaneous contamination.
Substances may contaminate surfaces directly or indirectly. Direct contamination occurs 
where the substance is placed on the surface as part of the task. The ambient contact 
follows when another worker uses the same surface for some other task. Indirect 
contamination may occur, for example, from deposition of airborne aerosol or dust or 
from condensation of vapour onto a cold surface. Detection of such contamination may 
be simply a matter of observation however, where such contamination is suspected a 
simple wipe test may be required.
The worker is critical in hazard control, since total avoidance of cutaneous contact with 
hazardous materials in many occupations cannot be accomplished by engineering 
controls alone. This requires the worker to use personal protection. The protective
5) Exposure Control
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equipment/clothing must fulfill requirements dictated by the type of physical and 
chemical exposure and type of work been carried out.
2.13(c) The use of protective gloves
Because hand dermatitis is the most common site of occupational contact dermatitis, 
gloves are the most useful protective gear. Because a large number of gloves are 
available, knowledge of the physical and biological hazards, and the job that is to be 
performed is required. Degradation and permeation are two types of chemical resistance 
properties that should be considered in the selection of gloves. The deterioration of the 
glove’s physical properties can cause the glove to crack, tear easily or dissolve so that 
large amounts of hazardous material come in contact with the skin.
Once it is determined that the glove is not degraded by a hazardous chemical, the second 
consideration is how much of the chemical diffuses through the glove. This is measured 
in the testing laboratory by breakthrough time and the steady-state permeation rate. No 
single glove is protective from all possible chemicals. Packham (1998b), introduces a 
simplistic glove selection chart (Appendix D).
It should be remembered that all glove materials are to some extent permeable to 
chemicals and that there is no universal protective material suitable for all possible 
chemicals (Packham 1998b).
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Occasionally, an allergy to a component of the glove or irritation from the glove itself, 
can be the cause of contact dermatitis, not the hazardous chemical for which glove 
protection was intended.
Of increasing significance is the problem of contact dermatitis caused by the proteins 
contained in natural rubber. This is of particular concern in those occupations where 
gloves are worn for extended periods of time, such as health care workers, hospitals, 
pharmaceutical manufacture, electronics. Natural rubber latex is a complex blend of 
different chemicals and some of the chemicals present in latex gloves are responsible for 
the Type IV skin reaction, allergic contact dermatitis (Hunt et al. 1995).
The National Institute for Occupational Safety and Health (NIOSH) recently published 
an article on latex gloves to promote the prevention of allergic reactions to natural 
rubber. Recent reports in the scientific literature indicate that from 1% to 6% of the 
general population and 8% to 12% of regularly exposed healthcare workers are 
sensitised to latex (Anon, 1997b).
2.13(d) Skin Allergy to natural rubber latex
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S E C T I O N  3.  R E S U L T S
SUB-SECTION 3.1 RESULTS OF INDUSTRIAL SURVEY 
3.1(a) Industries surveyed
A survey was carried out in order to determine the use and control of substances in Irish 
industry which would be classified as 'Skin Sensitisers’. The companies were selected 
from the Industrial Development listing of industries in Ireland. One hundred and 
twenty industries were surveyed. Of the industries surveyed 63 replies were returned. 
The respondence came mainly from the pharmaceutical (41%) and chemical (35%) 
industries. Other industries (24%) involved in the survey included, electroplating, 
electronic, healthcare and medical device manufacturers. The contents of this survey are 
included in a matrix (see Appendix F).
Industries Sirveyed
□ Pharmaceutical 
■ Chemical
□ Other______
35%
Fig. 5 Industries involved in the survey
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3.1(b) The number of employees within the industries surveyed
Table No.2
Number of Employees % of industries surveyed
10-50 23%
50-100 41%
100-250 14%
>250 21%
As can be seen from the above table the largest portion of the industries surveyed 
employ >50 people. 97% of the industries involved in the survey had Material Safety 
Data Sheets available to all employees.
3.1(c) Use of substances classified as skin sensitisers
Results from the survey reveal that 49% of industries use substances which are classified 
as ‘Skin Sensitisers’.
Some key findings from the surveys conducted
*49% of industries surveyed use substances classified as ‘Skin Sensitisers’.
*Only 2% of the industries surveyed have documented ‘Risk Assessments’ relating to 
the use of these substances in the workplace.
*None of the industries surveyed have ‘Skin Management Systems’ or ‘Skin 
Management Policies ’ in place at present.
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The results from the surveys conducted revealed that 49% of the industries surveyed 
reported cases of contact dermatitis within their workplace. 51% reported no cases of 
contact dermatitis among their workforce. Of the 49% that reported cases of dermatitis 
within their company 2% revealed that the contact dermatitis was as a result of allergy 
to natural rubber latex.
3.1(d) The reported cases of ‘Contact Dermatitis among Irish Industry
Cases of Contact Dermatitis among Irish 
Industries
55 
50 
45 
40
%  industries
35 
30 
25 
20
Contact Dermatitis No Contact Dermatitis
Results from Survey
Fig.6 Cases of Contact Dermatitis among Irish Industries.
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There are a number of provisions relating to the protection of workers from exposure to 
hazardous substances in the workplace. Among the industries surveyed there were a 
number of procedures for dealing with exposure to potential skin allergens and irritants.
3.1(e) Control measures for the prevention of ‘Occupational Skin Diseases’
Control measures used for the prevention of occupational skin exposure
in Irish industry
Method of exposure control
Fig.7 Control measures for the prevention of occupational skin exposure in Irish 
Industry.
From the industries surveyed it is clear that there is a heavy reliance on the use of 
personal protective equipment for the prevention and/or the control of occupational 
skin diseases. There is less emphasis on engineering controls which rank much higher in 
the overall hierarchy of control from an occupational health perspective. Administrative
controls by way of reducing the time spent in an area and/or the removal of a sensitised 
person from the area where there is the potential of exposure to the allergen is also rated 
above engineering controls for the prevention of occupational skin diseases within the 
context of the results of this survey.
3.1(f) Specific characteristics of substances classified as ‘Skin Sensitisers’ which 
make exposure control difficult.
Results from the survey revealed that although 80% of those industries surveyed found 
no specific characteristics of the substances that made exposure to them difficult to 
control, 20% reported some difficulties. The reported characteristics included 
substances present as powders, aerosols and fumes.
% industries which found exposure control 
difficult due to specific characteristics of the 
substance
□  Fumes 
■  Aerosols
□  Solids
□  None
Fig-8 % industries which found exposure control difficult due to specific 
characteristics of the substance.
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SECTION 4
DISCUSSION
S E C T I O N  4.  D I S C U S S I O N
In Ireland, at present, the control on the importation of substances is largely on the onus 
of the Revenue Commissioners who operate a tariff code system that groups chemicals 
into broad categories. It is not possible at present to identify individual chemicals 
imported and hence the information relating to the volume of substances classified as 
“Skin Sensitisers” imported into Ireland on an annual basis is currently unavailable.
In addition to this, a current list of substances classified by the European Commission is 
not accessible. Annex 1 of the EU Directive 67/548/EEC hasn’t been updated since 
1994 and is due for release within the next 2 years.
In an effort to determine the extent of the use and control of substances in Irish Industry 
which would be classified as‘Skin Sensitisers'a detailed survey was developed and sent 
to 120 industries within the Republic of Ireland (Section 3).
The results of this survey revealed the widespread use of substances which are potential 
skin sensitisers. All of the industries surveyed are involved in manufacturing, with more 
than half employing >50 people. The industries surveyed include, pharmaceutical, 
chemical, electroplating, electronic, healthcare and medical device manufacturers. The 
bulk of the companies involved in the survey were from the pharmaceutical and chemical 
sector.
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Almost half of the companies surveyed experienced cases of contact dermatitis among 
their workforce. Skin disease caused by a substance in the workplace is the most 
frequently encountered occupational illness and the results of the survey reitterate this 
fact. The statistical data reported in the Health and Safety Authority Annaul Report 
1997 noted that the highest number of cases of occupational disease were due to 
occupational dermatitis.
Further results of the survey revealed that there is a heavy reliance on personal 
protective equipment (PPE) to control exposure to potential skin allergens/irritants. 
Greater than half of the respondents reported reliance on the use of PPE to reduce or 
eliminate exposure to potential allergens. The hierarchy of control for occupational 
hygiene does not begin with personal protective equipment. Where a substance 
represents a potential to cause injury or damage to health, then the operation involving 
the substance should be investigated to determine the possibility of eliminating or 
substituting the substance. If this option is not feasible then adequate engineering or 
administrative controls should be put in place to reduce or eliminate exposure to the 
substance.
The use of personal equipment should only be addressed when the above approaches 
have been investigated. It is necessary to understand that while personal protective 
equipment offers protection to the individual carrying out a specific task, it offers no 
protection to any other person working in the area who also may be exposed to the 
substance although they may no be in direct contact with it. In order to comprehend
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the hazards of various chemicals such as those classified as ‘skin sensitisers’ one requires 
knowledge of the nature of the substance, its mode of action (i.e. sensitisation and 
elicitation of allergic reactions) and if and how it penetrates the skin. For this purpose 
education and training is essential.
Occupational skin diseases can occur in workers of all ages, in any work setting and 
cause a great deal of illness, personal misery and reduced productivity. Although the 
frequency of occupational skin disease often parallels the level of hygiene practiced by 
employers/employees, occupational skin diseases are largely preventable.
A variety of industrial chemicals are potential allergens. The incidence of allergic 
contact dermatitis varies depending on the nature of the materials handled and 
predisposing factors. Cross-sensitivity is an important phenomenon in which workers 
sensitised to one chemical will also react to one or more closely related chemicals. The 
cutaneous absorption rate of some organic compounds rises when temperature or 
perspiration increases. The absorption of liquid organic compounds may follow surface 
contamination of the skin or clothes while for other compounds it may occur directly 
from the vapour phase, in which case the rate of absorption is proportional to the air 
concentration of the vapours. The process may be a combination of absorption of the 
substances on the skin surface followed by absorption through the skin.
Of the industries surveyed 20% reported difficulty in exposure control as a result of 
specific characteristics of the substances. The majority reported difficulties with
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powders while fumes and aerosols were also reported as problematic. A number of 
industries are developing potent substances that require processing in a powder or other 
potentially respirable form. These substances may be active if inhaled or if they come in 
contact with the skin or eyes and can therefore pose a significant hazard to workers.
The need for determining worker exposure to hazardous substances in the workplace 
environment demands the availability of appropriate tested sampling methods. A critical 
part of the protocol for testing industrial methods is the preparation of controlled test 
atmospheres of the specific materials over the concerned range of interest. While the 
technology probably exists for developing validated sampling methods in each company, 
the cost for development of low concentration generation techniques are high and most 
companies may not have the in-house staff, facilities and equipment for such activities.
For technical reasons there are still no skin exposure limits to guide the employer nor 
techniques to measure skin exposure levels. As a result assessing whether a workplace 
is safe for skin exposure is still highly subjective and dependent upon the expertise of the 
observer. Substances, which cause sensitisation by skin contact, are not specifically 
identified in the Health and Safety at Work Act, 1997 Code of Practice (Appendix G). 
Further work is required to evaluate worker exposure to substances (allergens) which 
cause skin diseases. In order to do this the employer and the industrial hygienist need to 
have a standardised approach to assessing the exposure risks. They also require further 
information regarding the implementation of Skin Management Policies within 
companies, and the current listing of substances classified as skin sensitisers should be
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available. It is on the onus of the Health and Safety Authority of Ireland to address the 
problems of occupational skin diseases and to develop a more structured approach to its 
prevention. Employers require guidelines from the relevant authority in order to 
implement policies within their industry.
The loss of productivity resulting from skin problems, even though this may not be 
apparent in terms of sickness absence or compensation claims, is a real cost to the 
business in question and the government. The examination of government expenditure 
for disability and disablement benefit and the data available from Social Welfare 
payments for occupational dermatitis, reinforces the requirement for further 
improvements to the protection of workers exposed to substances that have the 
potential to cause skin disease.
Evaluation of the casual relationship, degree of disability and advice to the worker and 
industry is often overlooked or poorly done because of ignorance or lack of physician 
time. Adequate evaluation of the worker requires an extended office visit to obtain a 
detailed occupational history. If this is done dealing with workers compensation 
becomes relatively straightforward for the physician. The role of the physician is to 
determine the amount of alteration of health status i.e. impairment. Impairment is often 
blurred with determining the alteration in the patient’s capacity to meet personal, social, 
or occupational demands, i.e. disability. Disability is determined by professional 
disability rating personnel.
86
Detailed statistics on the actual incidence of occupational skin disease is hard to find in 
Ireland. For some years (until 1995) occupational dermatitis was not reported. Today 
with the involvement of dermatologists and physicians in the surveillance reports, further 
data should become more readily available.
There is no way of ensuring absolutely the prevention of occupational skin disease. 
What we are concerned with is the probability that the interaction between the skin and 
the working environment will result in damage to health. There is virtually no 
occupation where there is not some risk of skin disease occurring due to conditions in 
the workplace. However, certain occupations place workers at particularly high risk. 
An awareness of these risks can be of considerable benefit in both assessing the 
advisability of an individual taking up a particular operation and in creating an effective 
skin management system.
A skin management system would provide a structured approach, which would take into 
account different elements such as education and training, risk assessment, exposure 
assessment and monitoring, by integrating them into a single effective system. The 
system should not only ensure that the risk of damage to health through skin exposure is 
kept to an absolute minimum but also that any health problem which does arise is 
identified at the earliest possible stage so that remedial action can be taken. Skin 
management is about ensuring that the interaction between the skin and the working 
environment does not cause damage to the skin nor permit toxic chemicals to penetrate 
the skin and damage internal organs.
87
SECTION 5 
CONCLUSION
S E C T I O N  5.  C O N C L U S I O N
There is a widespread use of substances in Irish industry which are classified as ‘Skin 
Sensitisers’. There are very limited procedures in place for the prevention of 
occupational skin disease.
Further attention to detail is required to put in place a structured approach to the 
management of the exposure of workers to substances which have the potential to cause 
skin disease. The fact that the largest number of reported cases of occupational disease 
is occupational dermatitis it is clear that immediate action is needed to reduce the 
number of cases. In order to do this, there needs to be some guidelines for employers to 
follow by way of a standard protocol, detailing the criteria to be followed for assessing 
the use of substances which have the potential to cause skin disease.
Due to the lack of information available to employers, such as criteria for carrying out a 
detailed risk assessment for skin exposure along with an up to date list of substances 
classified as R43 (skin sensitisers), exposure limits and techniques to measure skin 
exposure, exposure control is difficult.
Until such time as this type of information and documentation become available to 
employers it is necessary for industries to develop in-house policies on skin 
management. A systematic approach involving risk assessment surrounding individual 
operations involving substances which have the potential to cause skin disease, should 
be investigated, implemented and documented.
88
The onus is on the Health and Safety Authority of Ireland to address the issues relating 
to occupational skin diseases and to develop a structured approach to its prevention, 
control and management. It is to the interest of employees, employers and the governing 
body of Ireland to reduce the incidents of skin diseases in the workplace
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APPENDIX A 
Allergic Contact Dermatitis and Patch Testing
Plate 53 Photoallergic contact der­
matitis from 6-methylcoumarin in a sun 
lotion. Note the sparing beneath the 
wristwatch.
Plate 35 Persistence of this generalized eczematous 
dermatitis requires patch testing to rule out an occult 
allergen.
from oak moss, a fragrance ingredient 
in this patient's husband’s cologne— 
a "consort" dermatitis.
Plate 34 This stastis dermatitis was made much 
worse after application of a topical antibiotic. 
Patch testing was positive to neomycin found in 
die topical antibiotic.
Plate 36 Allergic contact cheilitis due to 
cinnamic aldehyde found in the tartar control 
toothpaste diat this patient was using.
Plate 38 Chronic allergic contact 
dermatitis due to nickel in earrings and 
jeans buttons. Note involvement of the 
earlobe and neck as well as the 
abdomen.
Plate 23 This individual was allergic to benzo- 
caine found in a medication used to treat poison ivy.
Plate 25 This patient was allergic to quatemi- 
um-15 present in topical steroid used to treat a 
chronic irritant contact dermatitis. Her dermatitis 
flared and failed to clear when the topical steroid 
was used.
Plate 27 This individual was 
allergic to mereaptobenzothiazolc 
found in his flip-flops.
Plate 24 This nurse was allergic to the rubber 
gloves she wore when taking care of patients. Patch 
tests revealed positive reactions to thiuram mix and 
a portion of her gloves.
Plate 26 This child’s foot dermatitis was caused 
by an allergy to mercaptobenzothiazole found in 
her sneakers.
Plate 28 This fcx)t dermatitis was due to 
an undefined shoe component. Patch test 
results to parts o f shoes were positive, but 
test responses to rubber and leather anti­
gens in the standard and miscellaneous 
trays were all negative.
APPENDIX B
Contact Dermatitis: Criteria for evaluating probable 
occuaptional causation
C ontact dermatitis: Criteria for evaluating probable occupational causation
C riterion Yes No Don’t know
l. Is the clinical 
appearance consistent 
with contaci 
dermatitis?
Eczematous morphologic 
or histologic findings 
or
Adequate clinical 
description in history 
or medical records
Noneczema tous 
morphologic or 
histologic findings
2. Are there workplace 
exposures to potential 
cutaneous irritants or 
allergens?
3. Is the anatomic 
distribution of 
dermatitis consistent 
with cutaneous 
exposure in relation to 
the job task?
Supported by toxicologic 
data or clinical 
experience
Dermatitis is most 
severe on skin surfaces 
with maximal 
exposure (depends on 
physical form of 
irritant or allergen)
Not supported by 
toxicologic data or 
clinical experience
Dermatitis does not 
affect skin surfaces 
with greatest exposure
. Is the temporal 
relationship between 
exposure and onset 
consistent with contact 
dermatitis?
first or increased 
exposure preceded 
onset or aggravation 
and
Onset or aggravation 
within 6 months of 
first or increased 
exposure
Onset or aggravation 
preceded the first 
exposure
or
Onset or aggravation 
occurred more than 
3-4 days after last 
exposure (exception: 
initial allergjc 
reaction)
No dermatitis on clinical 
examination; 
inadequate clinical 
description in history' 
or medical records 
or
Noneczematous reaction 
sometimes mimicked 
by contact dermatitis 
(e.g., lichenoid 
eruptions)
Toxicologic properties of 
the exposure not 
known
Dermatitis affects skin 
surfaces with maximal 
exposure but is more 
severe on other body 
areas (excluding 
eyelid, facial, genital 
skin)
or
Dermatitis spares skin 
surfaces with maximal 
exposure but affects 
eyelid, facial, or 
genital skin 
Onset or aggravation 
occurred more than 6 
months after first or 
increased exposure
Criterion Yes No Don’t know
5. Are nonoccupational 
exposures excluded as 
probable causes?
6. Does dermatitis 
improve away from 
work exposure to the 
suspect«! irritant or 
allergen?
7. Do patch or 
provocation tests 
identify a probable 
causal agent?
Not likely on the basis 
of a thorough history 
or patch tests
Improvement not a 
result of concomitant 
medical treatment 
(e.g., intramuscular 
steroid)
and
Reexposure causes 
exacerbation
Positive reaction, with 
tests performed 
according to 
established guidelines 
and
Exposure has occurred 
in the workplace
Likely on the basis of a 
thorough history or 
patch tests
No improvement after 
more than 1 week 
away from work 
exposure
and
No concomitant 
exposure to other 
irritants or allergens
Negative reaction, with 
tests performed 
according to 
established guidelines 
and
All potential workplace 
allergens tested
Inadequate history 
or
Exposure to irritants or 
allergens both within 
and outside the 
workplace
Improvement coincides 
with medical 
treatment
or
Failure to improve may 
be attributed to other 
irritants or allergens. 
or
No improvement but 
away from work 
exposure less than 1 
week
Tests not performed 
according to 
established guidelines 
or
All potential workplace 
allergens or irritants 
not tested
APPENDIX C 
Reporting of Occupational Dermatological Diseases
R E P O R T I N G  O F  O C C U P A T IO N A L  D E R M A T O L O G IC A L  D I S E A S E S
CENTRE NAME _______________    FROM (date) \ \ TO \ \
Below are a list of the diagnostic groups to be used in the First column 
of the Reporting Table eg Group G.4 would be used in the column marked 
Group for a farmer with malignant melanoma.
A CONTACT DERMATITIS E MECHANICAL - Traumatic
1 Allergic
2 Irritant
3 Allergic and Irritant
4 Unclear
B CONTACT URTICARIA 
C FOLLICULITIS/ACNE
F NAIL - 
G Neoplasia
D INFECTIVE - 1 Tinea
O  Ta7  o  -v -  4 -  C2
¿-i
3 Others
1 Dystrophy
2 Paronychia
1 Keratosis
2 Basal cell
3 Squaemous cell
4 Melanoma
H OTHER DERMATOSES - (specify)
2
3
I have nothing to report .....
DETAILS OF ALL CASES. If one line is insufficient use the line below
eporter's Name __________________________________  Initials
sturn to Occupational Medical Service, 10 Hogan Place, Dublin 2
a p p e n d i x  d
Glove Selection Chart
G love selection chari
Gloves should only be used as indicated in this chart and only in 
accordance with the approved working practice.
1
/ )
.s ' ~'tL— .— .
Natural rubber, flock lined
Suitable for: Detergents, mild acids, water
Not suitable for: Solvents, strong acids, metalworking
fluids.
Use: Canteen, general cleaning (floors, toilets, 
washrooms etc.) but NOT machine cleaning.
i
Nitrile rubber, flock lined
Suitable for: Detergents, mild acids, water, some 
emulsions, some solvents.
Not suitable for: Toluene, Xylene, MEK,
Trichloroethylene, strong acids
Use: Protection against metalworking fluids, general
machine cleaning, but NOT where solvents are being
used.
Cotton lined PVC gauntlet
Suitable: As general protection against sharp edges, 
wet components, splinters in pallets etc.
Not suitable: For protection against any chemicals 
Use: Handling oil drums, pallets, castings etc.
Viton rubber, unlined
Suitable for: Solvents
Use: In degreasing plant, when handling toluene, xylene, 
trichloroethylene but NOT when handling hydrofluoric 
acid.
These gloves are for splash protection only - use only as 
directed in work procedure.
Butyl rubber, unlined
i Suitable for: Hydrofluoric acid 
Not suitable: Any solvent or other substance in the plant. 
Use: In degreasing plant when working with hydrofluoric 
acid.
These gloves are for splash protection only - use only as 
directed in work procedure.
APPENDIX E 
Survey Questionnaire
QUESTIONNAIRE SURVEY MSc.1999
NOTE: All the information on this questionnaire is considered confidential 
and will remain so . The information gathered is for informational purposes 
only.
Company Nam e__________________________________________;
Please place a tick V in the box for the correct answer
Q1. Nature of business;
Pharmaceutical Q  Chemical Q  Other 
specify other.
Q2. Number of employees
10-50 50-100 100-250 >250
U3 CD □  □
Q3. Type of company;
Manufacturing Q  Other
Q4. What are the main products manufactured;
Q5. Would any of the substances/chemicals that your company would 
use/manufacture be classified as Skin Sensitisers?
(i.e Have R43 risk phrase displayed on a Material Safety data sheet).
Yes j—j No □
QUESTIONNAIRE SURVEY MSc.1999
if yes;
Please list the substances;
Q6. Do any of the above listed substances (carrying R43 risk phrase) possess any 
specific characteristics that make the control of exposure to them difficult?
Yes |— | No |— |
if yes
What ? (e g solid/liquid, MP, BP,)
Q7. Have there been cases of contact dermatitis/skin irritation at your workplace? 
(i.e do any workers have skin allergies?)
Yes Q  No
Q8. What is the general procedure for dealing with a worker that develops/has and 
allergy to a specific substance;
Prevent exposure by;
(i) Removing the person from the area where the substance is been used
(ii) Provide the person with personal protective equipment to reduce/eliminate 
exposure.
(iii) Engineering controls
Q9. Was there a Risk Assessment carried out for the area/process where the 
substance classified as a skin sensitiser is used?
Yes HH No I I
If yes
Is this Risk Assessment documented?
Yes Q  No | |
Q10. Is there a Skin Management Plan/Policy in place in your company?
Yes Q ] No | |
If yes
Is this Skin Management plan/policy documented?
Yes No [ |
Q11. What types of personal protective equipment are available to someone 
working with a substance classified as a skin sensitiser?
I sincerely thank you for participating in this questionnaire.
Sonya Morrissey
APPENDIX F 
Survey Matrix
Questions__________________ Company Surveyed
No.1 Nature of business 1 2 3 4 s 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21
pharm X X X X X X X X X X X
chem X X X X X
other X X X X X
No.2 No.of employees
10 to 50 X X X
50 to 100 X X X X X
100 to 250 X X X X X
>250 X X X X X X X X
No.3 Type of company
Manufacturing X X X X X X X X X X X X X X X X X X X X X
Other
No.4 (not applicable)
No.5 R43 substances
Yes X X X X X X X X X X X X X X X X X X X X X
No
No.6 Specific characteristics
Yes (Y) X X X X X X X X
No (N) X X X X X X X X X X X X X
No.7 Cases of Contact Dermatitis
Yes(Y) X X X X X X X X X X X X X
No(N) X X X X X X X X
No.8 Control Measures
Personal Protective equipment X X X X X X X X X X X X X
Remove from area X X X X X X X X X X X X
Engineering controls X X X X X X X
No.9 Risk Assessment
Yes X
No X X X X X X X X X X X X X X X X X X X X
No.10 Skin Management Policy
Yes
No X X X X X X X X X X X X X X X X X X X X X
Questions Company Surveyed
No.1 Nature of business 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42
pharm X X X X X X X
chem X X X X X X X X X
other X X X X X
No.2 No.of employees
10 to 50 X X X X X X X
50 to 100 X X X X X X X X
100 to 250 X
>250 X X X X X
No.3 Type of company
Manufacturing X X X X X X X X X X X X X X X X X X X X X
Other
No.4 (not applicable)
No.5 R43 substances
Yes X X X X X X X X X X
No X X X X X X X X X X X
No.6 Specific characteristics
Yes X X
No X X X X X X X X X X X X X X X X X X X
No.7 Cases of Contact Dermatitis
Yes X X X X X X X X X X
No X X X X X X X X X X X
No.8 Control Measures
Personal Protective equipment X X X X X X X X X X X X X X X X X X
Remove from area X X X X X X X X
Engineering controls X X
No.9 Risk Assessment
Yes
No X X X X X X X X X X X X X X X X X X X X X
No.10 Skin Management Policy
Yes
No X X X X X X X X X X X X X X X X X X X X X
Questions Com pany Surveyed
No.1 Nature of business 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63
pharm X X X X X X X X X
chem X X X X X X X
other X X X X X
No.2 No.of employees
10 to 50 X X X X
50 to 100 X X X X X X X X X X X X X
100 to 250 X X X X
>250
No.3 Type of company
Manufacturing X X X X X X X X X X X X X X X X X X X X X
Other
No.4 (not applicable)
No.5 R43 substances
Yes
No X X X X X X X X X X X X X X X X X X X X X
No.6 Specific characteristics
Yes
No X X X X X X X X X X X X X X X X X X X X X
No.7 Cases of Contact Dermatitis
Yes X X X X X X X X
No X X X X X X X X X X X X X
No.8 Control Measures
Personal Protective equipment X X X X X X X X X X X X X X X X X X X
Remove from area
Engineering controls X X X X X X X
No.9 Risk Assessment
Yes
No X X X X X X X X X X X X X X X X X X X X >
No.10 Skin Management Policy
Yes
No X X X X X X X X X X X X X X X X X X X X
APPENDIX G
National Authority for Occupational Safety and Health 
Code of Practice for the Safety, Health and Welfare at Work 
(Chemical Agents) Regulations, 1994
NATIONAL AUTHORITY FOR 
OCCUPATIONAL SAFETY AND HEALTH
1997
CODE OF PRACTICE 
for the
Safety, Health and Welfare at Woik 
(Chemical Agents) Regulations, 1994
, 1997
Notice o f issue o f a Code o f  Practice
By virtue of Section 30 of the Safety, Health and Welfare at Work Act, 1989, 
and with the consent of Ms Eithne Fitzgerald, TD, Minister of State at the
Department of Enterprise and Employment given on the................. of November
1996, the National Authority for Occupational Safety and Health has on 
1996, issued a revised Code of Practice entitled "Code of Practice for 
the Safety, Health and Welfare at Work (Chemicals Agents) Regulations, 1994 
(S.I. No. 445 of 1994)". The text of the Regulations is shown in the Appendix.
The Code of Practice provides practical guidance as to the observance of 
Regulations 3 and 4 of the said Regulations as regards occupational exposure 
limits for the chemical agents listed in Schedule 1 to this Code.
This Code of Practice comes into effect o n ..................... 1997, and replaces the
Code of Practice issued by he National Authority for Occupational Safety and 
Health on 23id December, 1994. Schedule II to this Code lists the chemical 
agents for which the occupational exposure limit has charged in this Code of 
Practice compared to the Code issued in 1994.
0
Notice of the issue of this Code of Practice was published in the "Iris Oifigiuil" 
o f .................. 1996.
Signed ___________________
C D Body
Secretary to the Board 
-------------------- , 1996
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INTERPRETATION
For the purposes of this Code of Practice:
1. "Occupational Exposure Limit" means the maximum permissible 
concentration, of a chemical agent in the air at the workplace to which 
workers may be exposed, in relation to a 8 hour or a 15 minute reference 
period, as set out in Schedule 1 to this Code. The concentration of the 
chemical agent in air is expressed as parts per million (ppm), milligrams 
per cubic metre (mg/m3), or fibres per millilitre as appropriate.
"8 hour reference period" relates to the procedure whereby the 
occupational exposures in any 24 hour period are treated as equivalent to 
a single uniform exposure for 8 hours (the 8 hour time weighted average 
(TWA) exposure). The TWA may be expressed mathematically by:
(C, T, + C2 T2 + .........  + Cn Tn) / 8, where C}   Cn are the
occupational exposures and T , Tn are the associated exposure times
in hours in any 24 hour period.
'15 minute reference period" means the short term exposure reference 
period and is the sampling period used for assessing compliance with the 
associated exposure limit.
M
2. For exposure periods of less than the short term reference period, 
appropriate action shall be takento ensure that exposure does not exceed 
three times the short term exposure limit unless a suitable and sufficient 
assessment has indicated that such exposures do not present a risk to 
health.
3. For those substances which have not been assigned a short term exposure 
limit and where exposure periods are less than the 8 hour reference 
period, appropriate action shall be taken to ensure that exposure does not 
exceed three times the 8 hour exposure limit unless a suitable and 
sufficient assessment has indicated that such exposures do not present a 
risk to health.
4. Schedule 1 to this Code of Practice stipulates the occupational exposure 
limits for substances listed in that Schedule.
5. Within Schedule 1 five groups of substances are additionally identified as 
having the potential to cause particular and significant reactions in the 
employees following exposure. These groups may be identified by the
3
following notations which are included in the notes column of the
Schedule:
Cl Substances known to be carcinogenic for man (Category 1
carcinogens) to which the Safety, Health and Welfare at 
Work (Carcinogens) Regulations, 1993 (S.I.No. 80 of 1993) 
apply;
C2 Substances which should be regarded as if they are
carcinogenic for man (Category 2 carcinogens) to which the 
Safety, Health and Welfare at Work (Carcinogens) 
Regulations, 1993 (S.LNo. 80 of 1993) apply;
Sk Substances which have the capacity to penetrate intact skin
when they come in contact with it, and be absorbed into the 
body;
Asphx Gaseous chemical substances which may not produce
significant physiological effects in the exposed employee, but 
when present in high concentrations will act as simple 
asphyxiants;
Sens Chemical agents which following exposure may cause
sensitization of the respiratory tract and lead to asthma, 
rhinitis-' or extrinsic allergic alveolitis. Substances which 
cause skin sensidsation (allergic contact dennadds) are not 
specifically identified by this notation in the Schedule.
PERIODIC REVISION OF THE CODE OF PRACTICE
A revision of the occupational exposure limits listed in Schedule 1, to reflect 
current knowledge concerning the health hazards of the listed chemical agents, 
will be undertaken by the National Authority for Occupational Safety and Health 
on a biennial basis, in consultation with its Dangerous Substances Advisory 
Committee. Schedule HI to this Code provides a list of chemical agents for 
which it is the intention to introduce an occupational exposure limit or to change 
the existing occupational exposure limit in 1999. Comments may be made in 
writing to the Authority at its headquarters, 10 Hogan Place, Dublin 2, 
concerning any of the limits proposed.
cbi l l l sL96
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APPENDIX H
Health and Safety Authority of Ireland, Annual Report 
‘Surveillance of Work Related Diseases’, 1997
absent trom work tor more tnan tnree days in i v v j  ro in i w h  ana “t o w  in i w_>. n u w c v c i ,  
even at these levels the extent of occupational ill-health remains considerable The LFS returns 
indicate that the 4600 persons absent from work for more than three days due to occupational 
ill-health in 1995 accounted for 178800 work days lost and, in all, 185000 work days were lost 
due to occupaional ill-health during the year
Back to Index
Departm ent o f Social W elfare
The following is the data on occupational disease returns for 1994 and 1995 obtained mainly from 
the Department of Social Welfare, Ireland:
Disease ¡Cases Reported 1994 ¡Cases Reported 1995||Cases Reported 1996
Occupaional Dermatitisfl 44 1 63 38
Musculoskeletal _18. II 29 15
Occupational Asthma || 9 I .... 9 I 10
Asbestos-related 6 7 1 4
Occupational Deafness |j '• 1 > 2
Pesticide « J......  2 1 6
Coal or Silica-related |j 3 1 -*j
Tuberculosis ■ 3 ■ 1 1 1
Brucellosis A. !J -, .< A.
Other Lung Disease | 2 0 0
Other 7 5 2
Leptospirosis 0 0 3
TOTAL 105 123 ... __86 J
Back to Index
DISEASES REPORTED SWORDS
Disease Cases Reported 1995 Cases Reported 1996
Asthma 63 70
Inhalation Accidents 8 11
Allergic Alveolitis 6 5
Bronchitis / Emphysema 0 2
Infectious Diseases 1 1
Non-Malignant Pleural Disease 14 7
Mesothelioma 4 2
Pneumoconiosis 1 0
TOTAL 99 99
This table gives the totals recieved at the HSA from the "Surveillance o f Work Related
